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ABSTRACT OF THE DISSERTATION 
THE RELATIONSHIP AMONG SERUM LEVELS OF MANGANESE  
SUPEROXIDE DISMUTASE AND MITOCHONDRIAL DNA 8-HYDROXY-2’-
DEOXYGUANOSINE, AND DIETARY ANTIOXIDANTS INTAKE IN 
 TYPE 2 DIABETES 
By 
Michael Andrew McLean 
Florida International University, 2014 
Professor Fatma G. Huffman, Major Professor 
Oxidative stress plays a key role in the development of Type 2 Diabetes (T2D).  
This cross-sectional study examined the relationship among serum levels of manganese 
superoxide dismutase (MnSOD), 8-hydroxy-2’-deoxyguanosine (8OHdG), dietary 
antioxidant intakes and glycemic control in African Americans (n=209) and Haitian 
Americans (n=234) with and without T2D.   
African Americans had higher BMI (32.8 vs. 29.3 kg/m2), higher energy intake 
(2148 vs. 1770 kcal), and were more educated as compared to Haitian Americans; all 
variables were significant at p < .001.  Serum levels of 8OHdG and MnSOD for African 
Americans (1691.0 ± 225.1 pg/ml, 2538.0 ± 1091.8 pg/ml; respectively) were 
significantly higher than for Haitian Americans (1626.2 ± 222.9, 2015.8 ± 656.3 pg/ml; 
respectively).  8OHdG was negatively correlated with MnSOD (r = -.167, p < .001) in 
T2D.  Having T2D was negatively correlated with MnSOD (r = -.337; p < .01) and 
positively correlated with 8OHdG (r = .500; p < .01).  African Americans and Haitian 
Americans with T2D had fasting plasma glucose (FPG) levels of 143.0 ± 61.0 mg/dl and 
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157.6 ± 65.5 mg/dl, and A1C of 7.5 ± 1.8 % and 8.4 ± 2.4 %, respectively.  African 
Americans and Haitian Americans without T2D had FPG levels of 95.8 ± 13.2 mg/dl and 
98.7 ± 16.9 mg/dl, and A1C of 5.9 ± 0.4% and 6.0 ± 0.5%, respectively.  Dietary intakes 
of vitamin C and vitamin D were negatively correlated with FPG (r = -.21; r = -.19, p < 
.05) respectively.  Carotenoids negatively correlated with A1C (r = -.19, p < .05).  Lower 
levels of MnSOD were associated with lower levels of zinc, r = .10, p < .05, and higher 
levels of carotenoids r = -.10, p < .05.  Higher levels of 8OHdG were associated with 
lower levels of Vitamin D, r = -.14, p < .01, and carotenoids, r = -.09, p < .05. 
The results demonstrate greater oxidative mtDNA damage in persons with T2D 
compared to those without T2D and in African Americans compared with Haitian 
Americans.  The inverse relationship between dietary intake of antioxidants and oxidative 
stress implies a potential to reduce oxidative stress with diet. 
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 CHAPTER I 
 INTRODUCTION 
 The United States Census Bureau (2009) reported that the Haitian American 
population in the United States (U.S.) is approximately 830,000, two thirds of whom live 
in Florida and New York.  An intensive search of the literature resulted in very little 
health care information about the population of Haitian descent and it is unclear how their 
glycemic control, dietary intake of antioxidants, and oxidative stress biomarkers compare 
with African Americans.  African Americans have higher mean A1C (Kirk et al., 2006; 
Manickham et al., 2013), lower dietary antioxidants plasma biomarkers (Arab et al., 
2011), and increased oxidative stress biomarkers and inflammation (Feairheller et al., 
2011; Cook et al., 2013) than whites.  There are no studies on glycemic control, oxidative 
stress biomarkers, or dietary antioxidant in Haitians.  In addition, there are no studies that 
compared African Americans with Haitian Americans with and without Type 2 Diabetes 
(T2D) as investigated by this study. 
Diabetes is of epidemic proportions, and T2D accounts for 90% - 95% of all 
diabetes cases (Centers for Disease Control [CDC], 2011; O’Brien, Patrick, & Caro, 
2000).   According to the American Diabetes Association (ADA), there are 23.6 million 
children and adults in the United States who are afflicted with diabetes, with 
approximately 50% of whom are not aware that they have the disease.  It is estimated that 
5-10% of these patients have Type 1 (T1D), or insulin-dependent diabetes, and that the 
remaining have T2D, or non-insulin dependent diabetes mellitus (NIDDM; ADA, 2013; 
Demmer et al., 2013).  T2D is the focus of the current research. 
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The prevalence of diabetes in the United States is 8.3%, of which 12.6% of those 
diagnosed with T2D are of African descent (ADA, 2013; Demmer et al., 2013).  In 2007, 
Rosen et al. investigated the prevalence of T2D in the Haitians.  The investigators used 
fasting glucose to determine the prevalence of T2D and found that the prevalence of T2D 
was 33% (Rosen et al., 2007) in Haitians in the Miami-Haitian community.  A report 
prepared by The Health Council of South Florida for the Miami-Dade County Health 
Department (2008) documented that death rates for Blacks were twice that of Whites and 
Hispanics with T2D.  It is clear that health disparity exist between African Americans 
and Whites.  There are gaps in scientific literature regarding health biomarkers in 
Haitians and it is imperative to investigate the differences observed in the prevalence of 
T2D in African Americans and Haitians. 
Diabetes is clinically diagnosed by the use of a fasting plasma glucose (FPG) test 
or oral glucose tolerance test (OGTT), and a diagnosis of diabetes is made when the 
fasting plasma level of glucose is greater than or equal to 126 mg/dl (ADA, 2013).  The 
symptoms that are associated with diabetes are frequent urination, excessive thirst, 
extreme hunger, unusual weight loss, increased fatigue, irritability, and blurry vision.  
Diabetes risks may be categorized as either modifiable or non-modifiable.  The 
modifiable risk factors associated with diabetes are high blood glucose, obesity, 
hypertension, abnormal lipid metabolism, smoking, physical inactivity, and inflammation 
(ADA, 2013).  The non-modifiable risk factors are age, ethnicity, gender, and family 
history (Vanuzzo, Pilotto, Mirolo, & Pirelli, 2008; Giovannucci et al., 2010).   
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Oxidative stress plays an important role in the progression of complications 
associated with diabetes and the severity of the complications may be reduced with 
dietary antioxidant supplements (Gopaul et al., 2001; Kiss & Szabo, 2005; Rains & Jain, 
2011; West, 2000; Daien et al., 2013).  Montonen, Järvinen, Knekt, and Reunanen (2004) 
studied dietary antioxidant intakes and the development of T2D and found a negative 
relationship between T2D symptoms and dietary intake of antioxidants in the form of 
food or supplements.  
High levels of glucose contribute to an increase in reactive oxygen species (ROS) 
that up-regulate 8-oxoguanosine DNA glycosylase (OGG1) and decrease manganese 
superoxide dismutase (MnSOD), both of which are indicators of enzymatic antioxidants 
(Bolajoko et al., 2008; Ruchko et al., 2011).  This effectively induces mtDNA damage, 
whereby there is an increase in the byproduct mtDNA 8-hydroxy-2’-deoxyguanosine 
(8OHdG; Bolajoko et al., 2008).  8OHdG is a byproduct of the DNA repair mechanism, 
which has been used worldwide as a non-invasive method of identifying oxidative DNA 
damage that can occur both in vivo and in cell cultures (Harri et al., 2007; Patel, Bevan, 
Mistry, & Lunec, 2007; De Iuliis et al., 2009).  The mitochondrion also produces 
superoxide via reverse electron transport, and the body will normally up-regulate the 
antioxidant enzyme MnSOD to neutralize its damaging effects (Ceriello, 2003; Abraham 
et al., 2013).   
Other studies have shown that riboflavin (Cobianchi et al., 2008; Schramm et al., 
2013), n-acetylcysteine (Deneke, 2000), and vitamin E (Clarke, Burnett, & Croft, 2008; 
Niki, 2013) may all down-regulate the production of reactive oxygen species and assist 
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the body’s antioxidant defense system.  As such, the therapeutic use of antioxidant 
nutrients as food or supplements can prevent oxidative damage (Jat et al., 2013; Landete, 
2013). 
The mechanism of DNA damage appears to be directly associated with oxidative 
stress and impairment of mitochondrial oxidative phosphorylation (Lee & Pervaiz, 2011; 
Suzuki et al., 1999).  This impairment and defect results in the generation of the 
byproduct 8OHdG, which has been documented as a sensitive biomarker of oxidative 
stress, associated with a biochemical damaging effect on mitochondrial DNA (Ishikawa, 
Fujioka, Ishimura, Takenaka, & Fujisawa, 2007; Johnston et al., 2010).  8OHdG is the 
most frequently studied and validated biomarker of oxidative stress damage of the 
mitochondrial DNA (Cooke, Henderson, & Evans, 2009).  8OHdG has been shown to be 
stable in blood circulation and is measureable by the Enzyme-Linked Immunosorbent 
Assay (ELISA) methodology using serum (Breton, Sichel, Bianchini, & Prevost, 2003).  
There is a strong relationship between serum 8OHdG and creatine, but there is no 
relationship between serum levels of 8OHdG and urinary 8OHdG (Soini et al., 2011).  It 
is believed that 8OHdG excretion from the urine may be dependent on kidney function, 
which would justify not using urinary 8OHdG analysis in the T2D population (Soini et 
al., 2011). 
Statement of the Problem and Justification of the Study 
The prevalence of T2D in the general population is well documented, and 
research shows a disproportionate prevalence in ethnic/minority groups (Kim & Caprio, 
2011; Richard, Alexandre, Lara, & Akamigbo, 2011), who experience poor outcomes and 
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increased rates of complications associated with T2D (Richard et al., 2011).  There are no 
studies, however, that looked at 8OHdG and MnSOD in African Americans and Haitian 
Americans, two ethnically different groups that are normally grouped together.  This 
study provides data on the serum levels of 8OHdG, MnSOD, dietary antioxidant and 
A1C in African Americans and Haitian Americans.  The relationship between these 
variables was also determined.  The literature provides strong evidence of a protective 
effect of MnSOD on cell apoptosis.  Improvement in the deficient level of MnSOD may 
provide an ameliorative effect on diabetes complications resulting from programmed cell 
death (Kannan & Jain, 2000; Kowluru, Atasi, & Ho, 2006; Kaminski et al., 2012).  
This study also investigated the levels of dietary intake of antioxidants in African 
Americans and Haitian Americans, in addition to establishing a relationship between 
dietary intake of antioxidant nutrients and the serum levels of MnSOD.  Finally, this 
study provides valuable information for potential intervention studies on therapeutic 
approaches (Li & Zhou, 2011) to reduce progressive disorders associated with T2D. 
Purpose of the Study 
The purpose of this study was to determine the relationship between oxidative 
stress biomarkers that included mitochondrial DNA damage and serum MnSOD and to 
explore the relationship between these parameters of oxidative stress and dietary 
antioxidant intake.  Another purpose was to identify whether there are ethnic differences 
in these biomarkers in participants with and without T2D.  The study provides 
information on dietary intakes of antioxidant nutrients and their relationship with 
circulating oxidative stress biomarkers in persons with and without T2D.   
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Hypotheses and Specific Aims 
Aim 1: To determine differences in the serum levels of MnSOD and 8OHdG by 
diabetes status and ethnicity. 
Hypothesis 1a: Serum levels of MnSOD will be lower in participants with T2D as 
compared to those without T2D, independent of ethnicity. 
Hypothesis 1b: Serum levels of 8OHdG will be higher in participants with T2D 
when compared to those without T2D, independent of ethnicity. 
Hypothesis 1c: There will be an inverse relationship between serum levels of 
MnSOD and 8OHdG in participants with T2D, independent of ethnicity. 
Aim 2: To determine the relationships of serum MnSOD and 8OHdG with various 
dietary antioxidants by diabetes status and ethnicity.. 
Hypothesis 2a: Serum 8OHdG levels will be negatively associated with dietary 
intake of antioxidants, independent of diabetes status and ethnicity. 
Hypothesis 2b: Serum MnSOD levels will be negatively associated with dietary 
intake of antioxidants, independent of diabetes status and ethnicity. 
Aim 3: To examine the relationships of glycemic control (A1C) and fasting 
plasma glucose levels with various dietary antioxidants in T2D by ethnicity. 
Hypothesis 3a: There will be no relationship of A1C with any dietary antioxidants 
in T2D independent of ethnicity. 
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Hypothesis 3b: There will be no relationship of fasting plasma glucose level and 
any dietary antioxidants in T2D independent of ethnicity. 
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 CHAPTER II 
 LITERATURE REVIEW 
Oxidative Stress and Diabetes 
The literature shows that oxidative stress plays an important role in the 
progression of complications associated with diabetes and that there is the potential to 
reduce the complications of diabetes via supplementation with antioxidant therapeutics 
(Gopaul et al., 2001; Kiss & Szabo, 2005; Rains & Jain, 2011; West, 2000; Ren et al., 
2013).  High levels of glucose contribute to an increase in ROS that up-regulates 8-
oxoguanine DNA glycosylase (OGG1) and decreases superoxide dismutase (SOD) 
(Bolajoko et al., 2008).  A decrease in serum levels of SOD reduces the efficiency of 
neutralizing free radicals, which leads to an induction of mtDNA damage.  The result of 
the mtDNA damage is an increase in the byproduct 8OHdG (Bolajoko et al., 2008; De 
Iuliis et al., 2013).   
In the mitochondria, the reverse electron transport chain produces harmful 
superoxide radical (O2-) and other ROS (Wen et al., 2013).  The body responds to the 
production of O2- by up-regulating the antioxidant enzyme SOD in order to neutralize the 
oxidizing effects from the superoxide (Ceriello, 2003; Di Naso et al., 2011).  
Antioxidants such as riboflavin, n-acetylcysteine, and vitamin E may down-regulate the 
production of ROS and assist the body’s antioxidant defensive system, which has 
therapeutic implications (Clarke et al., 2008; Cobianchi et al., 2008; Deneke, 2000; Lee et 
al., 2013; Landete, 2013). 
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Endothelial dysfunction and insulin resistance may result from oxidative stress 
(Pereira et al., 2008; Petocco et al., 2010).  Additionally, there is a positive relationship of 
insulin resistance with 8-epi-PGF2-alpha, an indicator of oxidative stress, among persons 
with and without diabetes (Gopaul et al., 2001).  Gopaul et al. (2001) also examined 
individuals with diabetes who had endothelial dysfunction, assessed by a non-invasive 
digital pulse wave photoplethysmography.  The finding suggested an increase in arterial 
stiffness with the duration of diabetes.  There was an increase in 8-epi-PGF2alpha in 
subjects with diabetes when compared to controls without diabetes.  8-epi-PGF2alpha 
positively correlated with fasting blood glucose, triglycerides, and insulin resistance.  
Gopaul et al. (2001) showed that, in T2D, development of endothelial dysfunction and 
insulin resistance are preceded by oxidative stress.   
Oxidative stress is considered a common pathway for such health conditions as 
neurological degenerative disorders, diabetes, and various cancers.  A number of studies 
have documented the role of oxidative stress in T2D and in MetS in both adults and 
children (Abate, Vatansev, & Erkul, 2004; Baines, 1991; Block et al., 2002; Ren et al., 
2013).  Ren et al. (2013) observed that ROS may contribute to the T2D by damaging the 
normal function of islet β cells via apoptosis of mitochondrial structure.  Block et al. 
(2002) found that increased fruit consumption correlated with decreased lipid 
peroxidation and that the levels of the oxidative stress biomarker malondialdehyde 
(MDA) positively correlated with inflammation, as determined by C-reactive protein.  
They also found that oxidative stress biomarkers were inconsistent among races; i.e., 
African Americans had higher levels of thiobarbituric acid-reactive substances (TBARS), 
no difference in levels of MDA, and lower levels of Iso-P levels as compared to 
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Caucasians.  The level of oxidative stress appears to correlate with the degree of 
mitochondrial dysfunction in Asian Indians with T2D compared to healthy controls 
(Khan et al., 2011).   
Khan et al. (2011) studied lymphocytes which were harvested by a density 
gradient centrifugation technique and were then used for DNA studies and 
immunophenotyping.  The researchers used mtDNA/nDNA as a biomarker for the 
pathophysiology of the disease.  Oxidative DNA damage and cell death were determined 
via ELISA.  In this way, Khan et al. (2011) examined the role of mitochondrial 
dysfunction in immune pathophysiology and were able to identify a strong association 
between lymphocytic nuclear DNA damage and T2D as well as an increase in levels of 
circulating pro-inflammatory cytokines in subjects with T2D as compared to controls. 
Khan et al. (2011) hypothesized that the inconsistency of oxidative stress biomarkers 
between ethnicities may be due to differences within an ethnic group.  Researchers 
normally recruit and classify participants into one group based upon shared distinctive 
physical appearance with ancestral origin, such as African Americans, Afro-Caribbean, 
and Africans may be classified as Blacks or African Americans.  However these ethnic 
groups may have large health disparities and different associated risk factors which may 
influence the serum levels of oxidative stress biomarkers (VanEenwyk, 2010). 
Three factors that contribute to oxidative stress are an increase in oxidant 
generation, such as catechols, semiquinones, and reactive quinones; antioxidant 
protection degeneration; and oxidative damage repair dysfunction.  Free radicals that 
contribute to oxidative stress status (OSS) include, but are not limited to, catechol, 2,3 
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DHBA, lipid peroxides, reduced glutathione, glutathione peroxidase (GSH-Px), and SOD 
(Nelson et al., 2006).  Oxidative stress factors may contribute to mtDNA damage inside 
the cell.  The byproduct of this DNA damage is an endonuclease repair nucleotide called 
8OHdG, which is facilitated by an endonuclease repair enzyme (Nelson et al., 2006). 
Oxidative Stress and Obesity 
 Obesity is the accumulation of excessive fat that have been correlated with 
increased mortality and health impairment (WHO, 2012).  Abdominal fat is a major risk 
factor for diseases which are related to obesity and BMI, total body fat and waist 
circumference have been shown to be positively correlated with oxidative stress.  It is 
clear that there is a positive relationship of oxidative stress with obesity, regardless of the 
etiology of obesity (Savini et al., 2013). 
There is evidence of an increased chance of developing health related diseases 
with increasing obesity and BMI, and these findings are higher among some ethnic 
groups (Pan et al., 2004; Shai et al., 2006).  Since BMI is correlated with oxidative stress 
levels and Vimalananda et al. (2011) reported that Haitians had lower mean BMI than 
African Americans, determining the relationship between oxidative stress levels in these 
two ethnic groups is warranted. 
Oxidative Stress and Dietary Antioxidants 
 It has been proposed that the root cause and complications of T2D is associated 
with oxidative stress and that dietary intakes of antioxidants nutrients have been shown to 
have beneficial effect on the body’s natural defense mechanisms by inhibiting ROS (Han 
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et al., 2007) and preventing mitochondrial dysfunction.  Published studies have shown 
that accumulated oxidative stress biomarkers and free radicals damages lipid membranes, 
DNA and influences insulin resistance and -cell dysfunction (Morris, et al., 2002; 
Ceriello et al., 2004; Wright Jr. et al., 2006) and there is growing body of evidence to 
support the theory that oxidative stress may be reduced by dietary antioxidant intakes 
(Frei, 2004; Siedlak et al., 2009; Mullner et al., 2013 ). 
  In the review by Frei, a number of studies have shown that dietary antioxidants 
such as vitamin C, E, -carotene provide protection against ROS in various biological 
systems.  He reported that several case-controlled studies have shown an increase in the 
DNA oxidation marker, 8OHdG, in subjects with certain types of cancers, cigarette 
smokers, and persons with diabetes and suggested that dietary antioxidants may be a 
viable therapeutic option.  His suggestion was supported by a number of observational 
studies that reported an inverse relationship between dietary antioxidant intake and 
oxidative DNA damage. 
Another dietary antioxidant that has been well studied and has been shown to be 
inversely correlated with oxidative stress is vitamin D.  It has been reported that vitamin 
D deficiency have been correlated with an increased risk of cardiovascular disease and 
have been reported to be associated with obesity (Codoner-Franch et al., 2012; Earthman, 
et al., 2012; Alemzadeh et al., 2008; Pacifico et al., 2011). Codoner-Franch et al. (2012).   
The researchers studied the relationship between relationship of vitamin D and oxidative 
stress biomarkers in Caucasians.  Overall, these researchers found a significant 
relationship of insufficient vitamin D levels and obesity, a risk factor for T2D.   
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Similarly, Gradinaru et al. (2012) studied vitamin D status and oxidative stress in T2D 
and reported an inverse relationship of vitamin D status with oxidative stress biomarkers.  
 Siedlak et al. (2009) studied the effect of a diet rich in alpha-lipoic acid in a 
mouse model expressing amyloid- protein precursors.  The oxidative stress biomarkers 
used in this study was heme-oxygenase -1 and 4-hydroxynonenal.  The researchers 
reported a significant decrease in the level of these oxidative stress biomarkers in the 
animals fed the diet of alpha-lipoic acid compared to wild-type mice which served as 
controls. 
Mullner et al. (2013) studied the effect of vegetables and PUFA-rich plant oils on 
DNA strand breaks in T2D subjects.  Diabetes and non-diabetes participants were 
assigned to either a intervention or control group.  Participants from the intervention 
group were provided vegetable rich and PUFA-rich oils.  Blood samples were collected at 
baseline, and at 4, 8, and 16 weeks and oxidative stress assessment was conducted to 
determine DNA damage in mononuclear cells.  The study showed that participants with 
diabetes had statistically significant reduced levels of DNA strand breaks and it appears 
that the healthy oils provided some protection to the DNA in the participants with 
diabetes.   
Other research provided evidence of an association between diet and oxidative 
stress and the possible role of dietary antioxidants in the reduction of complications 
associated with T2D.  Additionally, some foods may have powerful antioxidant 
properties which have been reported to have health benefits such as the Mediterranean 
diet (Savini et al., 2013).  The effect of this diet on health conditions is related to the 
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dietary benefits from fruits, vegetables, whole-grains, nuts, fish, moderate wine 
consumption and olive oil.  A study by Ortega-Azorin et al. (2012) provided evidence 
that dietary patterns were more beneficial than specific foods and that adherence to one 
such dietary pattern, the Mediterranean diet, provided the health benefits of a high quality 
diet.  
The dietary intake of antioxidant foods or supplements may reduce oxidative 
stress and, subsequently, lessen mtDNA damage (Weissenberger et al., 2010).  Generally 
it is believed that the identification of dietary factors that play a key role in the protection 
of the mitochondria and the alleviation of symptoms associated with diabetes is crucial to 
the development of preventive measures.   Due to the variability in ethnic dietary choices 
and food preparation, it is important to determine whether there are ethnic differences in 
oxidative stress biomarkers and mtDNA damage.  There are few published studies on the 
relationship of antioxidant nutrient intake and mtDNA damage among different ethnic 
groups.  This study identified the differences in dietary intakes of antioxidants for African 
Americans and Haitian Americans and also investigated the relationships between the 
dietary antioxidants and oxidative stress biomarkers. 
Oxidative Stress and Biochemical Mechanism 
There is convincing clinical and experimental evidence of the biochemical 
mechanism of oxidative stress. Experimental evidence establishes that there is a 
significant reduction in glutathione levels and erythrocyte CuZn-SOD activity in 
individuals with diabetes, with or without cardiovascular disease (CVD) (Chen, Osio, & 
Anderson, 1999; Chatuphonprasert et al., 2013).  The underlying mechanism of oxidative 
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stress is a reduction of oxygen (O2) that can have reversible or irreversible effect on cells, 
organs, or tissues.  This biochemical effect results from intermediate compounds that are 
produced from the reduction of O2, which produces O2-, hydrogen peroxide, and hydroxyl 
anions. 
There is strong evidence that oxidative stress is increased by several physiological 
conditions such as hyperglycemia, exposure to environmental pollutants, and the 
generation of ROS by DNA during its normal biochemical functions (Poljsak & Fink, 
2014).  Oxidative Stress may also be generated from different sources in the body such 
the oxidation of polyunsaturated fatty acid (PUFA; West, 2000; Bae et al., 2011) and 
calcified regions of stenotic aortic valves and atherosclerotic arteries (Miller et al, 2008). 
In the mitochondrial membrane, ROS is generated during the production of 
nicatinamide adenine dinucleotide phosphate (NADPH) and catalyzed by the enzyme 
NADPH oxidase (Bae, 2011).  There are two biochemical pathways for the production of 
NADPH.  The first pathway is the hexose monophosphate shunt, where the insulin-
induced enzyme glucose-6-phosphate-dehydrogenase (G-6PD) is required to oxidize 
glucose-6-phosphate (G-6P) to produce 6-phosphogluconate.  The second pathway is 
driven by another insulin-dependent enzyme, 6-phosphogluconate dehydrogenase (6-
PGD), to oxidize 6-phosphogluconate, which produces more NADPH.  The enzyme 
isocitrate dehydrogenase (ICD) is critical to the oxidative decarboxylation of isocitrate to 
alpha-ketoglutarate, utilizing either NAD+ or NADP+ as cofactors.  In a rat model, 
superoxide dismutase (SOD) inactivates the NADP-dependent isocitrate dehydrogenase 
(ICD), resulting in a statistically significant reduction in ICD activity (Batini-Haberle & 
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Benov, 2008).  Since NAD+ and NADH+ are both key components of cellular respiration 
and energy metabolism, then a reduction in ICD activity would profoundly affect 
apoptosis and increase oxidative stress levels. 
Batini-Haberle & Benov (2008) studied the reduction in ICD activity levels and 
found that it was due to the neutralizing and reducing effects of SOD on the production of 
NADPH.  NADPH, a reducing agent, is involved in immunological reactions in immune 
cells and in respiratory burst reactions where there is a production of ROS.  A similar 
mechanism is observed in immune response to the presence of bacteria or fungi in the 
blood stream (Omori et al., 2008).  In persons with diabetes, it is observed that 
neutrophils which participate in the respiratory burst require priming by NADPH oxidase 
(Omori et al., 2008).  Abnormal insulin production will impair the hexose 
monophosphate shunt and reduces the rate of NADPH production.  This reduction in 
NADPH influences the oxidative defense systems, e.g., the glutathione peroxidase and 
catalase enzymatic system (Bono, 1987).  This is because NADPH plays a crucial role in 
the activities of enzymes such as catalase and SOD, which are anti-oxidative defense 
systems whose function is to reduce ROS.  The effect of the impairment is the elevation 
of the levels of serum ROS, which results in oxidative cell damage (Bono, 1987). 
Miller et al. (2008) studied the biochemical mechanism that may contribute to the 
stenotic aortic valves and atherosclerotic arteries and he found that a major contributor is 
the activity of uncoupled nitrous oxide species (NOS).  In addition, uncoupled nitrous 
oxide contributes to the production of superoxide and ROS and may assist in the 
disruption of cell membranes, proteins, lipids, and cellular constituents.  The 
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mitochondrion is a cellular component that is responsible for a vast majority of ROS 
production (Bae, 2011). 
Diabetes and Manganese Superoxide Dismutase (MnSOD) 
The major defense from free radical damage in the mitochondria is provided by 
the manganese superoxide dismutase (MnSOD), which is an enzyme unique to the inner 
mitochondrial space (Curtis et al., 2007).   Manganese superoxide dismutase is regarded 
as the most powerful enzyme in the defense against active oxygen species, producing 
hydrogen peroxide and oxygen (Curtis et al., 2007).  The mitochondria are the source of 
superoxide, which has been shown to be a major contributor to the progression of 
diabetes complications in persons with diabetes (Kowluru et al., 2006). 
There is evidence that MnSOD may provide protection to diabetic 
cardiomyopathy in a diabetic mouse model by reducing ROS and improving 
mitochondrial function (Shen et al., 2006).  The researchers identified that ROS 
participate in diabetes-induced heart muscle apoptosis, and they reported that this 
pathology was preventable with adequate antioxidants.   
Manganese superoxide dismutase (MnSOD) is an enzyme that is encoded by a 
single-copy gene. Its expression is controlled by the GC-rich promoter region that 
contains numerous specificity protein 1 (SP-1) and activating protein 2 (AP-2) binding 
sites (Hitchler, Oberley, & Domann, 2008).  Hitchler et al. (2006) have shown that the 
MnSOD expression is regulated by epigenetic factors rather than just variations in DNA 
sequence.  This enzymatic regulatory mechanism may provide an explanation of the 
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reduction in MnSOD enzyme activity and that its production is influenced by both 
genetic and environmental factors (Hitchler et al., 2006). 
Madsen-Bouterse, Zhong, Mohammad, Ho, and Kowluru (2010) conducted 
research on retinal endothelial cells and found evidence for the protection of 
mitochondrial DNA by the nuclear specific enzyme MnSOD.  The researchers examined 
the DNA damage caused by hyperglycemia using a q-PCR method and identified the 
genes which were expressed using RT-PCR methodology.  Madsen-Bouterse et al. (2010) 
found that there was an increase in mtDNA damage in retinal endothelial cells which 
were exposed to hyperglycemia and that MnSOD play a significant role in preventing 
mtDNA damage.  A similar protective role of MnSOD on mtDNA damage was reported 
by Sadi, Eryilmaz, Tutuncuoglu, Cingir, and Guray (2011).  In another study (Zhong & 
Kowluru, 2011) that used rats, the results indicated that hyperglycemia reduced MnSOD 
activity, which, in turn, resulted in a 60% decrease in gene transcription.  Overall, there 
are few studies that examine the relationship between MnSOD and mtDNA damage, and 
most were conducted using cell cultures or animal models.  Because these experimental 
designs used animals, it is not known whether the results are generalizable to humans. 
In an animal study, Kowluru et al. (2006) investigated the effects of diabetes 
complications in MnSOD-transfected rats.  Wister rats were caused to be diabetic with 
the use of streptozotocin and were maintained as such through the 11-month duration of 
the study.  The control group of transfected rats was fed a diet that was void of the 
antioxidant lipoic acid, while the experimental group had a diet that was supplemented 
with lipoic acid.  Both groups were fed for 11 months, after which time they were 
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sacrificed, and the retina was harvested and serum was collected and stored for analytical 
studies.  The researchers used commercially available ELISA kits to determine MnSOD 
activity and 8OHdG levels; they also determined the development of retinopathy by 
pathological examination of the harvested retina.  They observed an increase in the level 
of MnSOD and the progression of diabetic retinopathy in MnSOD-transfected rats when 
compared to the non-transfected rats.  
In the same study Kowluru et al. (2006) also examined the effect of lipoic acid 
therapy on the MnSOD activity in the rats with diabetic retinopathy.  They found a 
significant decrease in the enzymatic activity of MnSOD within the mitochondria of 
diabetic rats compared to rats without diabetes.  In addition, there was similar cytosolic 
SOD activity between diabetic rats and non-diabetic rats.  A statistically significant 
increase in the MnSOD level in the plasma of rats that consumed diets with lipoic acid 
was also found.  They concluded that there was a decrease in oxidative stress in the lipoic 
acid-supplemented group, as determined by a decrease in 8OHdG level. 
Garcia-Ramirez et al. (2008) have shown that subjects with diabetes, with or 
without CVD, had significantly reduced SOD activity when compared to a control group.  
The participants with diabetes were in the late stages of diabetes complications.  
Mitochondrial DNA was then determined via a real-time peripheral blood mononuclear 
cells (PBMC).  MnSOD activity was determined from homogenized PBMC via an assay 
that measured inhibition of the reduction of cytochrome C by moving oxygen.  
Mitochondrial DNA damage and mitochondrial content were used as indicators of the 
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degree of oxidative stress.  MnSOD activity was used as a mitochondrial antioxidant 
defense index.   
Mitochondrial DNA damage was significantly greater in the subjects with 
diabetes than without diabetes.  MnSOD activity was significantly increased in the 
peripheral blood mononuclear cells (PBMC) of persons with T2D, as compared to the 
controls without diabetes.  The researchers concluded that the increased MnSOD activity 
was due to an adaptive response to oxidative stress.  Overall, the results showed that there 
was a reduction in mtDNA damage due to the degree of mtDNA oxidation (a result of 
oxidative stress) and that MnSOD was up-regulated as a response to the oxidative DNA 
damage. 
The literature shows that there is an inverse relationship between serum MnSOD 
levels and T2D complications; i.e., the over production of serum levels of MnSOD levels 
were observed in subjects with diabetes complications as compared to subjects without 
diabetes complications.  There is accumulating evidence that mitochondrial substrate 
sensitivity is increased in the skeletal muscle of subjects with T2D when compared to 
subjects without T2D.  A decrease in mitochondrial substrate sensitivity correlates with 
reduced extracellular MnSOD levels (Larsen et al., 2011).  In addition, it appears that 
mitochondria do not function efficiently in the skeletal muscle of subjects with T2D, and 
the size of the mitochondria, as measured by electron microscope, is smaller than that 
seen in a control group (Kelley, He, Menshikova, & Ritov, 2002). 
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There were no recent studies found in the literature that evaluated the relationship 
between the serum levels of MnSOD and either African American or Haitian American 
subjects with and without T2D. 
Diabetes and 8-hydroxy-2’-deguanosine (8OHdG) 
Diabetes contributes to numerous health complications such as neuropathies, 
blindness, and macular degeneration.  The major mechanisms that cause the 
complications are the activation of protein kinase C (PKC), advanced glycation end 
products (AGE), and an increase in polyol and hexosamine pathway flux (Rolo & 
Palmeira, 2006).  The progression of diseases which are associated with T2D may be due 
to mutations in the mtDNA and mtDNA copy reduction.  Rolo and Palmeira (2006) have 
shown an association between the mitochondrial nuclear-encoded glucose transporters, 
glucose-stimulated insulin secretion, and nuclear-encoded uncoupling proteins. 
One of the effects of oxidative stress is the damage to the mitochondria.  The 
damage is associated with an increase in mitochondrial reactive oxygen and the 
generation of nitrogen species, i.e. Nitrogen oxide.  MnSOD plays a key role in the 
protection of the mtDNA damage from oxidative stress (Li & Zhou, 2011).  Lumini, 
Magalhaes, Oliveira, and Ascensao (2008) stated that the dysfunction of the mitochondria 
produces reduced uncoupling proteins (UCPs).  UCPs are located in the inner membrane 
of mitochondria that function as transporters.  UCP1 is predominantly found in brown 
adipose tissue and is involved in respiration, UCP2 is ubiquitous and is highly expressed 
in the lymphoid system, and UCP3 is solely expressed in skeletal muscle and heart.  The 
UCP2 that is expressed in the pancreas has been linked to hyperinsulinemia (Fleury et al., 
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1997).  In addition, under-expressed UCP2 is associated with a reduction in glucose-
induced insulin secretion (Saleh, Wheeler, & Chan, 2002).  Lumini et al. (2008) indicated 
that exercise may reverse the mitochondrial defect, but the mechanism by which this 
occurs is not clearly understood.  This finding was corroborated by Jun et al. (2009) in a 
study of male and female Koreans between the ages of 20 and 70 years.  From the 1,500 
subjects, the researchers collected data on dietary intake, physical activity, 
anthropometrics, and biochemical analysis, including single-nucleotide polymorphism 
genotype, using fasting blood specimen.  Low physical activity was correlated with 
under-expression of UCP2, BMI, and waist circumference. The polymorphism in the 
UCP2 gene was related to T2D.  
In hyperglycemic subjects, elevated levels of oxidative stress contribute to the 
progression of diabetes complications.  Research has shown an association between 
diabetes complications and mitochondrial DNA damage (Madsen-Bouterse et al., 2010; 
Kowluru et al., 2006).  The effect of oxidative stress on the mitochondria is evidenced by 
an increase in the conversion of deoxyguanine (dG) to 8OHdG in DNA (Suzuki et al., 
1999; Xu et al., 2004).  Suzuki et al. (1999) investigated mtDNA4977 deletion in muscle 
DNA and 8OHdG content in diabetes and found that there was an increase in delta-
mtDNA4977.  The study showed that an increase in mtDNA4977 was proportional to the 
severity of the diabetes complications. The study also showed that increased 8OHdG was 
related to the severity of diabetes complications (Suzuki et al., 1999).  The mechanism of 
DNA damage appears to be directly associated with oxidative stress and defects in the 
mitochondrial oxidative phosphorylation (Lee & Pervaiz, 2011; Suzuki et al., 1999). 
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Diabetes and Diet 
According to the National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDKD), the improvement of the quality of the diet may reduce the risk of 
T2D by lowering blood glucose and cholesterol levels, lower BMI, and in some cases it is 
preventable by early detection of insulin resistance and subsequent high quality dietary 
intervention.  In persons with T2D, the risk of T2D may be reduced by including daily 
exercise and physical activity, abstaining from smoking and alcohol, and maintaining a 
healthy weight, and dietary management (Martin-Timon et al., 2014;  ADA, 2013; Izandi 
et al, 2013).  Of these cofactors of T2D, dietary management is probably the most 
difficult therapeutic intervention for individuals with T2D (Evert at al., 2014). 
Several studies have demonstrated that T2D may be prevented with dietary 
modifications and lifestyle changes (Bazzano, Serdula, & Liu, 2005; Caro, Ward, & 
O’Brien, 2002; O’Brien et al., 2000; Tuomilehto et al., 2011).  According to Bazzano et 
al. (2002), the development of T2D may be influenced by a combination of 
environmental factors, such as low dietary fiber and high fat intakes, high glycemic index 
and high glycemic load of the diet, being overweight or obese, and physical inactivity.  
Tuomeliheto et al. (2011) observed that T2D may be prevented when several lifestyle 
targets were followed, such as loss of weight, decrease fat intake, increase dietary fiber 
intake, and increased physical activity.  Participants who followed a healthy diet had 
favorable health outcomes.  
  A healthy diet is defined as being of high quality when it includes whole grains, 
healthy fats and proteins, unrefined foods, and fruits and vegetables (Akbaraly et al., 
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2011; McCullough et al., 2002; Larsen et al., 2010).  Harvard School of Public Health 
provided evidence that eating more whole grains, fruits, and vegetables will reduce the 
risk of T2D by 20 percent (ADA, 2014).  In this study, the researchers determined the 
quality of diet with the use of the 110-point Alternate Healthy Eating Index 2010.   
The inability to follow a recommended high quality diet may be influenced by 
ethnic culture, lifestyles, and beliefs (Anderson-Loftin et al., 2005).  African Americans 
(Liburd, 2003) and Haitian Americans may find it challenging to follow a high quality 
diet because of cultural and ritualized nature of food choices and socio-economic status 
(Huffman et al, 2013).  The adherence to a high quality diet has been shown to influence 
glycemic control in African American women with T2D (Skelly et al., 2009) and thereby 
the possible delay of the onset of complications (ADA, 2013). 
The effect of diet and environmental factors on the progression of disorders 
associated with T2D has been well documented (Kallio et al., 2007; Tuomeliheto et al., 
2011).  In the Kallio et al. (2007) study, participants had a body mass index (BMI) 
(Kg/m2) of 26-40, were between the ages of 40 and 70, and satisfied at least three criteria 
for a diagnosis of MetS, using National Cholesterol Education Program (NCEP, 2011) 
guidelines.  The researchers examined the effect of a carbohydrate-modified diet on gene 
expression in abdominal subcutaneous adipose tissue and on glucose and insulin 
metabolism (Kallio et al., 2007A diet comprised of rye-pasta influenced gene expression 
by down-regulating genes linked to insulin signaling, which resulted in a 21% decrease in 
the cell size of adipocytes (Kallio et al., 2007).  A diet that consisted of oat-wheat-potato 
appears to activate the genes that are associated with inflammation and oxidative stress, 
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without any observable change in adipocyte cell size (Kallio et al, 2007).  The researchers 
established that the type of dietary carbohydrate played an important role in modulating 
gene expression.   
Serum Levels of MnSOD and Oxidative Stress 
The literature reports experimental and clinical findings of a link between 
MnSOD, oxidative stress and impaired mitochondrial function in diabetes.   MnSOD is 
localized in the mitochondria and serves to protect the mtDNA from oxidative stress 
damages (Li & Zhou, 2011).  The damages to the mtDNA can impair the functions of 
cells (Garcia-Ramirez et al., 2008) and contribute to progressive disorders associated 
with diabetes.  Although serum level of MnSOD is well documented in subjects with 
cancers (Lin et al., 2005; Nishida et al., 1993; Schadendor et al., 1995) and 
cardiovascular disease (Shen et al., 2006; Miriyala et al., 2011), the data for T2D is 
sparse and the clinical significance of serum MnSOD is yet to be determined.  The data 
on serum MnSOD levels in T2D would provide information that may be used to guide 
and monitor dietary antioxidant intakes as a means to reduce oxidative stress (Garcia-
Ramirez et al., 2008). 
The enzyme MnSOD reduces oxidative stressors; however, it is well documented 
that the plasma levels of SOD in patients with T2D diabetes is markedly reduced (Garcia-
Ramirez et al., 2008).  Abnormally low levels of SOD may contribute to mtDNA damage 
(Garcia-Ramirez et al., 2008).  A possible therapeutic approach to reduce or slow the 
mtDNA damage caused by oxidative stress is to improve the plasma levels of MnSOD, 
which can be accomplished through the use of hormones such as HCG or melatonin 
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(Kozirog et al., 2010) as well as through antioxidant micronutrients such as copper, 
selenium, and manganese (Otsu, Ikeda, & Fujii, 2004). 
Kozirog et al. (2010) treated diabetes subjects with 5 mg of melatonin.  The 
subjects were instructed to take one capsule of melatonin before bedtime for a period of 
60 days.  Blood pressure (BP) and a fasting blood specimen were taken to establish 
baseline data, including serum lipid profiles and oxidative stress biochemical markers 
such as TBARS, SOD, and glutathione peroxidase (GSH-Px).  After a 2-month 
intervention period, BP and blood sample were taken for the determination of the effect 
of the melatonin intervention.  The researchers observed a significant improvement in 
blood pressure, lipid profiles, and glutathione. 
The effect of mineral supplements on SOD enzymatic activity levels has shown 
positive influences, including the improvement of catalase enzymatic activity, another 
antioxidant enzyme (Kozirog et al., 2010; Beauchamp & Fridovich, 1971).  HepG2 cell 
lines are hepatocellular carcinoma-derived cells that are conventionally used to conduct 
in-vitro studies of the mechanism that occurs in liver cells.  The researchers studied the 
effect of supplements, which were either replenished or depleted, of a mineral of interest. 
Supplements with or without Cu and Zn, which were used to feed the cell lines, and SOD 
activity was determined (Beauchamp & Fridovich, 1971; Otsu et al., 2004).  Mineral 
depletion appeared to down-regulate both Cu/ZnSOD and MnSOD to 70%-80% of 
baseline activity level.  Zn was shown to be more critical than Cu in the up-regulation of 
MnSOD, which may be due to Zn’s involvement in MnSOD induction (Otsu et al., 2004).  
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Further research is needed to evaluate effect of antioxidants supplementation on plasma 
levels of MnSOD and on mtDNA damage. 
Serum Levels of 8OHdG and Oxidative Stress 
 Oxidative stress has been implicated in a number of diseases, including cancers 
and Type 2 Diabetes.  It is clear that 8OHdG is an oxidative stress biomarker found to be 
elevated in patients with diabetes and may contribute to diabetes complications (Pan et 
al., 2008; Al-Aubaidy et al., 2011).  Clinical studies show that serum 8OHdG is 
measurable by ELISA method and proven to be a reliable biomarker for oxidative DNA 
damage (Basavarai, et al., 2013; Pagano, et al., 2014). 
The acceptable specimen for the determination of 8OHdG levels are serum, cell 
lysate, peripheral blood mononuclear cells, and urine (Chen et al., 2008).  Urine samples 
for 8OHdG testing require 24-hour urine collection, and it is demanding on the subject 
involved in the collection process (Khadem-Ansari et al., 2011). The predominant 
biomarker that is used to assess the degree of mtDNA damage is 8OHdG and the 
accumulation of 8OHdG in serum has been reported in patients with T2D (Jamil et al., 
2014).  Recently, a number of 8OHdG ELISA test kits have been validated for serum 
specimens and the test kits have documented performance characteristics such as 
sensitivity, specificity, and inter- and intra-assay reproducibility.  Akihiko, Odamaki, and 
Hishida (2003) have shown that the serum level of 8OHdG, using ELISA test kits, was 
significantly higher in subjects with diabetes, as compared to subjects without diabetes. 
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Oxidative Stress and Glycemic Control among Ethnic Groups 
 Emerging literature shows that all Blacks should not be grouped together and 
identified as African Americans (Huffman et al., 2011; Huffman et al., 2013).  
Feairheller, Diaz, Sturgeon, Williamson, and Brown (2011) examined total antioxidant 
capacity (TAC), protein carbonyls (PC), and TBARS among African Americans and 
Caucasians.  They found that, even though there were no statistical differences between 
African Americans and Caucasians for age, BMI, or blood pressure (diastolic and 
systolic), there were statistically significantly higher levels of oxidative stress in African 
Americans.  To examine the effect of geographical influences on oxidative stress, Deeq et 
al. (2008) conducted a cross-sectional study that included African Americans from 
Indianapolis, Indiana, and Yoruba from Nigeria.  The researchers used 8-Isoprostane as 
the biomarker for oxidative stress.  They found evidence of higher oxidative stress levels 
in Nigerians, which may be dietary and environmentally influenced. 
Research has shown that diabetes, high blood pressure, and other cardiovascular 
disease (CVD) risk factors affect African Americans more than they do Caucasians 
(CDC, 2011; Liutkeviciene, Lesauskaite, Asmoniene, Zaliuniene, & Jasinskas, 2010).  
One of the most important independent risk factors for the progression of complications 
associated with diabetes is hemoglobin A1C (O’Connor et al., 2011).  Morbidity and 
mortality are highest in African Americans with peripheral artery disease (PAD).  A 
meta-analysis   (Kirk et al., 2013), examined glycemic control as measured by A1C and 
found that African Americans values were more elevated than non-Hispanic whites with 
diabetes.  The authors reported that the observed disproportionate A1C levels between 
African Americans and non-Hispanic whites may be due to access to medical care, less 
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optimal diabetes care, and medication affordability (Karter et al, 2002; Rhee et al., 2005; 
Kirk et al., 2005; Ofili, 2001).  This may be related to the lack of agreement of the 
correlation between A1C and average glucose in certain subjects (Standards of medical 
care in diabetes, 2014).  Glycation rates may be race dependent, consequently A1C levels 
may have ethnicity variability (Ziemer et al., 2010; Kumar et al, 2010).  Glycation 
involves oxidative reactions that may adversely affect DNA function (Pun & Murphy, 
2012). Since glycation rates could be dependent on ethnicity, then oxidative stress levels 
could cause a higher rate of DNA damage in subjects with T2D.  There is evidence of a 
strong inverse correlation between DNA damage, oxidative stress, and apoptosis with 
levels of A1C (Khan et al., 2011), providing a measure of the average blood glucose level 
over 2-3 month period.  Subjects whose diabetes status is out-of-control are more likely 
to developed diabetes complications.  It is well documented that glycemic control 
influences the extent of oxidative stress (Marling, Shubrook, Vernier, Wiley, & Schwartz, 
2011; Nahkjavani et al., 2010) and that A1C is a reliable biomarker and indicator of 
glycemic control.   
Ethnicity and Dietary Antioxidant Intake 
 The literature on dietary antioxidants intake is varied and not conclusive.  
Suksomboon, Poolsup, and Sinprasert (2011) reviewed nine randomized clinical trials on 
vitamin E supplementation and glycemic control in subjects with T2D but found no 
significant changes in A1C levels as a result of supplementation with vitamin E.  In a 
study by Camargo et al. (2006), subjects with T2D were administered pharmacological 
dose of vitamin E supplements over a 4 month period and it was observed that it did not 
impact A1C.  Alternatively, in a review by Unnikrishnan et al. (2012), it was reported 
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that high doses of Vitamin C and E have lowering effect on A1C.  In their review, they 
reported that the mechanism for the lowering effect of A1C is related to the reduction in 
the rate of hemoglobin glycation.  Arab et al. (2011) compared dietary antioxidant intake 
between African Americans and Caucasians.  They found that healthy African Americans 
were more likely to be overweight and that being overweight contributed to inflammation 
and oxidative stress status.  In addition, they found that 32% of African Americans, as 
compared to 45.2% of Caucasians, took dietary supplements.  Overall, they found a 
significant correlation between dietary antioxidant intake and plasma concentrations of 
carotenoids as determined by high-performance liquid chromatography (HPLC).  African 
Americans had a significantly lower intake of antioxidants.  The researchers believed that 
the difference may have been due to food preparation, dietary sources, genetic variants, 
or BMI (Arab et al., 2011).  Huffman, Serge, and Himburg (2011) found intra-racial 
differences in caloric intake and BMI in African Americans and Haitian Americans. 
Manganese (Mn) is an important antioxidant that scavenges free radicals and is 
secondary to biochemical functions, behaving as a backup free radical scavenger that is 
similar to MnSOD, especially in regard to oxidative stress (Reddi & Culotta, 2011).  
Although there is a lack of data on the mechanism by which Mn participates in the 
cellular adaptation to oxidative stress (Reddi & Culotta, 2011), research has shown that 
the antioxidant activity is regulated by nutrient-sensing pathways. 
The data from published works shows that diabetes status influences manganese 
physiological status by various etiological factors such as viral infection, autoimmunity, 
genetics, and obesity (Walter et al., 1991).  The mechanism which may influence the 
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manganese status in diabetes may be related to dysfunction in mineral metabolism 
(Walter et al., 1991).  It is well documented that Mn, an essential component of the 
enzyme MnSOD (Greger, 1998).  Hope et al. (2006) reported that dietary Mn intakes 
were lower in non-tea drinkers compared with tea drinkers and that tea is a major source 
of dietary Mn.  In their study, the levels of MnSOD were determined via RT-PCR from 
blood collected from volunteers who were assigned to either a tea-drinker and non-tea 
drinker group.  This study showed that dietary Mn intake can improve the Mn status in 
the body and that there was an inverse relationship of Mn plasma levels and MnSOD of 
leucocytes. 
The literature indicates an overwhelming evidence of the negative influence of 
oxidative stress and MnSOD in inflammation and cancer (Fu et al., 2011; Li et al., 2011; 
Suzuki et al., 2001).  Because Mn and iron (Fe) play an important role in the biosynthesis 
of MnSOD (Hassan & Schrum, 1994), data on the dietary intake of Mn may provide 
valuable information on possible biochemical requirements for the production and up-
regulation of MnSOD.  There is some evidence that vitamins and minerals play an 
important role in slowing the progression of disease associated with T2D (Martini et al., 
2010) and reducing oxidative stress levels. 
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 CHAPTER III 
 METHODOLOGY 
Study Design 
This study used a cross-sectional design to explore the relationship between two 
biomarkers that are closely linked to oxidative stress and the biomarkers’ relationship to 
diet and disease state.  The data and specimens that were used for this study were 
collected previously (Huffman et al., 2007).  This study was conducted with Haitian 
Americans and African Americans with and without T2D.  The investigator of this study 
fully participated in data collection.  After the participants signed an informed consent 
form, they were assigned a unique identifier, and blood was collected and processed 
immediately and stored for analysis at a later time by this investigator.  The unique 
identifier was the only link between the participants’ demographic information and 
laboratory assessment.  The participants’ personal information, as linked with the unique 
identifier, was kept in a locked cabinet.  This study was approved by the Institutional 
Review Board at Florida International University’s Office of Research Integrity under 
IRB exemption number 073112-01 (Appendix E). 
Anthropometric Measurements 
Participants had their height, weight, and waist circumference recorded by a 
trained research assistant.  Measurements for height and weight were obtained by using a 
SECA balance scale (Seca Corp., MD, US).   Waist circumference was measured 
horizontally with a measuring tape.  The participants completed a standardized socio-
demographic dietary assessment questionnaire (FFQ) and a medical questionnaire that 
included medical history, prescribed medications, and the use of supplements.  The 
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control group participants (without T2D) underwent the same procedures as did the 
participants with T2D.  This was a cross-sectional study that used data from male and 
female participants, aged 35 years or older, with and without T2D.  Ethnicity (Haitian 
American and African American) and diabetes status (T2D or no diabetes) were self-
reported but verified by blood test.   
Recruitment of Participants 
Participants were initially recruited by randomly generated mailing lists 
purchased from Knowledge Base Marketing, Inc., Richardson, TX, U.S.  This company 
provided two mailing lists generated from multiple databases of African Americans, 
identified as having or not having T2D, from Miami-Dade and Broward Counties, 
Florida, U.S.  Approximately 7,550 letters were mailed to African American participants 
with and without T2D.  Approximately, 6.3% (n = 477) of the letters were returned due to 
an invalid addresses.  From the remaining delivered letters, 4% (n = 256) responded 
(Figure 1).  
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Figure 1 – Recruitment of African American Participants
  
     
1.   Local diabetes educators and community health practitioners in Miami-Dade and 
Broward Counties.  Several local diabetes educators who were either former 
students or who were in close contact with the Department of Dietetics and 
Nutrition at Florida International University (FIU) were identified.  Letters of 
invitation, which described the study, were mailed to the diabetes educators and 
health professionals in Miami-Dade and Broward counties and requested their 
cooperation in recruiting individuals. 
2.   FIU faculty, staff, and students.  Invitational flyers were distributed to all 
university faculty, staff, and students who used the university-wide e-mail system; 
these flyers contained an explanation of the research protocol and requested their 
assistance in the study. 
Mailed, 7550
Returned, 
n=477, 6.3%
Responded, 
n=256, 4.0 %
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3.   Several residential and rental facilities were used to conduct interviews and 
complete questionnaires.           
4.   Advertisements.  Print advertisements were placed in local Haitian newspapers 
and the principal gathering places of these groups, such as churches, 
supermarkets, and restaurants.  Radio advertisements on local Creole stations also 
were aired. 
When the target recruitment goal was reached for all ethnic groups, efforts to 
recruit participants were discontinued.  Interested participants were initially interviewed 
on the phone, at which time the study’s purpose was explained and the age, gender and 
ethnicity of the responders were determined.  To ascertain T2D status, each participant 
who self-reported as having diabetes was asked for the age of diagnosis and initial 
treatment modalities.  Participants who did not qualify for the study (N = 28) consisted of 
those who were younger than 35 years old (N = 12), another ethnicity (N = 5), or who 
had other chronic diseases or illnesses (N = 11).  If a potential participant was determined 
to be eligible, then his or her participation was requested at the Human Nutrition 
Laboratory at FIU.  Participants were instructed to refrain from smoking, consuming any 
food or beverages except water, and engaging in any unusual exercise for at least eight 
hours prior to their blood collection.  
The study was approved by the Institutional Review Board at FIU.  The purpose 
and the protocol of the study were explained to the participants, and their written consent, 
in either English or Creole, was obtained prior to the commencement of the study.  
Laboratory results showed that 12 participants (Haitian American = 8, African American 
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= 4) who reported as not having diabetes were reclassified as having T2D, according to 
American Diabetes Association standards.  These participants were given their laboratory 
results, referred to their physician.  A total of 443 (234 Haitian American, 209 African 
American) participants were included in the final data analysis. 
Sample Size and Power Analysis 
In this study, multiple linear regressions were the primary statistical analysis 
method used.  It was necessary to determine the sample size for an independent variable 
(e.g., total antioxidants) added to the equation explaining an additional 1.6% of the 
variability of the dependent variable (e.g., serum MnSOD levels) after controlling for 
eight covariates.  Using a sample size calculator for multiple regression (GPower3, 2010, 
Faul et al, 2009) with eight covariates and a partial R2 of 0.18 for the added predictor, 
80% power, and a 5% significance level, a sample size of 431 participants was necessary.  
The main study had enrolled 515 participants, and had complete data on 443 participants.  
This study was sufficiently powered for the statistical analysis. 
Compliance 
A fasting specimen is an important requirement to the assessment of the 
biomarkers that were evaluated in this study.  To ascertain that the subjects were 
compliant with at least an 8-hour fast, they were asked to fill out a questionnaire that 
included an item regarding fasting, and the researcher asked the participant about his or 
her fasting compliance.  In addition to a fasting glucose analysis (to verify fasting), the 
researcher determined the level of glycosylated hemoglobin A1C.  Hemoglobin A1C was 
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used for analysis of diabetes self-management and to help determine the presence of 
T2D.  
Nutritional Assessment 
Dietary intake of calories and nutrients were measured using the semi-quantitative 
food frequency questionnaire (FFQ; 97GP 2006 version copyrighted at Harvard 
University, Boston, MA, U.S.), which has been extensively validated and standardized in 
several multiethnic population-based studies (Willet et al., 1985).  On the FFQ, 
participants self-report average consumption of specified amounts of various foods over 
the past year, with response categories that ranged from “never” to “six or more servings 
per day.”  In addition to food items, the FFQ included questions about type and duration 
of vitamin/mineral supplement use and specific details about fat, salt, and sugar used in 
cooking and as condiments.  Each of the completed FFQs was reviewed for incomplete 
answers or blank responses before the interview was completed.  Researchers completed 
the incomplete items by probing of the subjects before they left.     
Daily servings for food groups were calculated by summing the frequency factors 
for all related food items.  Macro- and micro-nutrient intakes were calculated by 
multiplying frequency of consumption by the nutrient value of the food item, as obtained 
from the Harvard University Food Composition Database (Willet et al., 1985).  The 
calculated consumption of dietary antioxidants was used to determine the relationship 
between MnSOD and 8OHdG and antioxidants intakes. 
Blood Collection and Biochemical Assessment 
 Participants were asked to fast for at least 8 hours before blood was collected by a 
certified phlebotomist.  Blood was collected by venipuncture into serum separator tube 
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(SST) and ethylenediaminetetraacetic acid (EDTA) tubes.  Fasting Plasma Glucose levels 
and A1C were measured from the blood which was collected in the EDTA tube by 
Laboratory Corporation of America, Miami, FL (LabCorp®).   Twenty milliliters of 
fasting venous blood was collected in serum separation tubes, centrifuged, and processed, 
and aliquots were stored in a -70° Celsius freezer by the researcher of this study.  
Biochemical studies were performed to determine total cholesterol, triglycerides, low-
density lipoprotein, and high-density lipoprotein via a methodology from Cobas Mira, 
Roche Diagnostics (Bowling & Katayev, 2010).  Glucose levels were measured using the 
hexokinase enzymatic method, and a monoclonal antibody method (Bayer Corporation, 
Diagnostic Division, Tarrytown, NY, USA) was used to determine glycated hemoglobin 
(A1C).  Participants were provided with a copy of their biochemical assessment, 
including a cardiovascular risk analysis which was calculated from the lipid profile. 
 Serum levels of MnSOD and 8OHdG were determined.  ELISA was used as the 
method of detection of these biomarkers.  Presently, there are numerous ELISA kits 
available that can detect the levels of 8OHdG in serum. There has been good correlation 
between plasma levels of 8OHdG and tissue 8OHdG by this method (Park et al., 2001).  
These correlations support the use of plasma levels of 8OHdG to predict the degree of 
mtDNA damage. 
The gold standard for the identification of 8OHdG in tissue, blood, and urine is 
high-performance liquid chromatography tandem mass spectrometry (HPLC-ms), which 
is as effective as the more readily available high-performance liquid chromatography-
electrochemical (HPLC-EC) detection methodology (Harri et al., 2007).  These methods 
require expensive equipment, analytical software, and highly skilled operators.  The 
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availability of monoclonal antibodies to 8OHdG, however, provided a framework for the 
development of a method of detection (ELISA) that is cheaper, requires less costly 
equipment and reagents, and does not require highly trained experts to perform and 
analyze specimens.  The ELISA kit platform is reliable, reproducible, and validated for 
the detection of 8OHdG in urine, cell lysates, and serum.  In several studies, ELISA has 
been shown to be as effective as HPLC (Breton et al., 2003; Yoshida et al., 2003).  
Several manufacturers have developed highly sensitive 8OHdG ELISA kits that require a 
pretreatment of serum before performing the analysis. 
In this study serum MnSOD was detected via the ELISA method.  The literature 
search for the rational in determining MnSOD in serum in T2D is missing, however the 
evidence is convincing that serum levels of MnSOD is a useful tool and potential clinical 
biomarker to predict disease associated with viruses (Tamai et al., 2011),  and cancers 
(Schadendor et al., 1995; Nishida et al., 1993).  The reagents were available on the open 
market and they were purchased from Cayman Chemicals (Ann Arbor, MI).  The assay 
also requires a plate reader with a 450-nm reading capacity.  All supplies and equipment 
were available to the investigator in the Human Nutrition Laboratory at FIU. 
Determination of serum 8OHdG 
Several studies report an association of serum 8OHdG levels in subjects afflicted 
with different chronic diseases.  The literature provides evidence that elevated levels of 
serum 8OHdG is associated with poor prognosis in patients with ovarian cancer (Pylvas 
et al., 2011), T2D, kidney disease (Kato et al., 2003), and also with obesity (Al-Aubaidy 
& Jelinek, 2011).  The source of the circulating 8OHdG was not determined in neither of 
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these studies nor our study.  Kikuchi et al. (2002) reported that elevated level of 8OHdG 
was observed in serum but not in cerebrospinal fluid in patients with Parkinson’s disease, 
which suggest that 8OHdG may have originated from peripheral tissues.   
The reagents used in the measurement of serum 8OHdG were manufactured by 
Cayman Chemicals (Ann Arbor, MI; Catalog#589320) and the analytical procedure was 
followed precisely according to the manufacturer’s instructions.  The micro titer plate 
found in this kit utilized an anti-mouse IgG antibody and an 8OHdG enzyme conjugate.  
The kits contained all reagents necessary to perform analysis except for a micro titer plate 
reader which was available in the Human Nutrition Laboratory at FIU.  
The principle of this assay is based on the competition between oxidative 
damaged guanine species and an 8OHdG-acetylcholinesterase conjugate (tracer).  
Aliquots of standards, controls and specimen were pipetted according to micro titer plate 
layout and then the tracer was added.  The micro titer plate was incubated for 18 hours at 
4 degrees C, after which they were rinsed with a wash buffer and then an Ellman’s 
Reagent was added.  The plates were incubated for 120 minutes at room temperature and 
then the absorbance was measured by a micro titer plate spectrophotometer.  The estimate 
of the oxidative DNA damage was determined by comparing the absorbance of an 
unknown specimen to the standard curve determined by the assay.  In this study, the 
intra- assay and inter-Assay CV for the 8OHdG assay was calculated to be 6.2%and 
4.5%, respectively, which is an acceptable range of variation. 
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Determination of serum MnSOD 
The scientific literature contains very few studies on the relationship of serum 
MnSOD and health related conditions in humans, however we found numerous reports on 
the association of MnSOD with diseases in animal models.  In human models, Lin et al. 
(2005) studied the role of serum MnSOD in patients with gastric cancer and found a 
weak, but not significant, association.  Tamai et al., 2011) studied the role of serum 
MnSOD and hepatocellular carcinoma (HCC) and reported a significantly higher level of 
MnSOD in subject with HCC compared with subjects without HCC.  Additionally, they 
reported that their findings were clinically significant in that serum MnSOD may be used 
to predict prognosis in HCC.  There were no recent studies publications that dealt with 
serum MnSOD with MnSOD in tissue.  We found one study where Koshida et al. (1996) 
reported positive relationship with testicular tumors with serum MnSOD but not with 
tissue MnSOD.  The source of circulating MnSOD is not clear (Schandendorf et al., 
1995) and the limited reports suggest that serum MnSOD is a sensitive biomarker for 
malignant tumors (Koshida et al., 1996; Ishikawa et al., 1990). 
The reagent kits used in this study were manufactured by Young In Frontier Co., 
Ltd (Seoul, Korea; Catalog# LF-EK0104) and the analytical procedure was followed 
according to the instructions found in the manufacturer’s package insert.  The contents of 
the reagent kit included all reagents necessary for the analysis, which included a micro 
titer plate that had been pre-coated with a monoclonal antibody specific to human 
MnSOD.  Prior to the analyses, the samples were thawed and brought to room 
temperature.  Aliquot of the sample, standards, and controls were pipetted into the pre-
coated micro titer plate and was then incubated at room temperature with constant 
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agitation for 2 hours.  The wells were then washed.  A working antibody solution was 
added and then allowed to incubate for 1 hour at room temperature.  After incubation, the 
wells were washed again and a working AV-HRP solution (conjugate) was added to each 
well.  Wells were allowed to incubate for an additional 30 minutes at room temperature.  
The plate was washed and a substrate solution was added to each well and incubated for 
10 minutes.  A stop solution was added at the end of incubation period.  The micro plate 
was then read on a 450nm using a micro plate reader.   In this study, the intra- assay and 
inter-Assay CV for the MnSOD assay was calculated to be 5.5% and 3.1%, respectively. 
Covariates 
 The covariates in this study were age, gender, smoking status, education, BMI, 
energy intakes, ethnicity, and diabetes status.  These variables were shown to be strongly 
associated with oxidative stress and ROS (Zhu et al., 2012; Whaley-Connell et al., 2012; 
Pryor, 1997; Moller et al., 1996).  Oxidative stress and reactive oxygen species levels 
progressively increase with aging (Andriollo-Sanchez et al., 2005; Junqueira et al., 2004; 
Harman, 1956) and may be related to a decline in the body’s primary antioxidant defense 
system.  There is evidence of gender-related differences in oxidative stress levels and the 
literature report lower levels of oxidative stress in female genders than males, suggesting 
that the female gender have a reduced susceptibility for DNA damage than males (Hakim 
et al., 1012; Vina et al., 2011).  Additionally, Hakim et al. reported greater levels of 
oxidative stress biomarkers in subjects who smoke compared to non-smokers.  Oxidative 
stress increases with BMI and age in African Americans (Wonisch et al., 2012; Warolin 
et al., 2014) and oxidative stress levels have been found to be higher in African 
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Americans than in Whites. (Morris et al. (2012).  Oxidative stress has been proposed as 
the root cause in T2D and excessive levels of ROS have been in subjects with T2D 
(Phillips et al., 2004; Wright et al., 2006).  
Statistical Analysis 
 Data were analyzed using SPSS, Version 20.0 (SPSS Inc., Chicago, IL, U.S.).  
Descriptive statistics were used, and the results were expressed either as means ± 
standard deviations, or frequencies and percentages.  The significance level was set as p < 
.05 for all tests.  The relationships between the variables were analyzed using analysis of 
covariance (ANCOVA), Pearson’s correlations, or multiple linear regression.  Since 
MnSOD was not normally distributed, the natural logarithm of MnSOD was used in all 
analyses.  The ANCOVA was used to compare the levels of 8OHdG and MnSOD 
between ethnic groups.  Pearson’s correlations and multiple linear regressions were used 
to determine the associations between dietary antioxidant intake and MnSOD and 
8OHdG by ethnicity and as well as their interaction.  Full models included all potentially 
significant demographics (age, gender, smoking status, energy intake, and education) and 
the physical covariate (BMI).  Final models included age, gender, and all covariates 
which had p-values ≤ .20 for the Pearson correlations with the dependent variables and 
diabetes status.  Multiple linear regression analysis was used to compare the continuous 
dependent variables, i.e., enzymes and mtDNA damage byproduct, with diabetes status 
and ethnicity. 
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 CHAPTER IV 
 RESULTS 
This chapter is organized according to the research questions and into sections 
according to the aims of the study.  The first section includes the general characteristics 
of the study participants by ethnicity and diabetes status.  First, socio-demographics are 
presented and then oxidative stress markers, and finally glycemic control biomarkers.  
The second section contains correlations among socio-demographics and biomarkers.  
The tests of the hypotheses are presented in the last section.  
Section 1:  General Characteristics of Participants  
This cross-section study compared African Americans and Haitian Americans by 
their ethnicity and diabetes status.  There were complete data for 443 participants:  233 
with T2D and 210 free of diabetes; 209 African Americans and 235 Haitian Americans. 
Table 1 presents the socio-demographics by ethnicity.  African American were 
significantly younger (M = 53.3 vs. M = 55.6; p < .018), had a higher BMI (kg/m2) (M = 
32.8 vs. M = 29.3; p < .001), higher percentage of smokers (34% vs. 6.4%; p < .001), a 
higher calculated energy intake (kcal/day) (Md = 1925 vs.  Md = 1650; p < .001) and 
were more educated (more than high school, 57% vs. 33%; p < .001) as compared to 
Haitian Americans.  
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Table 1 
General Characteristics of Participants by Ethnicity 
 Ethnicity  
Variables 
African 
Americans 
(n = 209) 
Haitian 
Americans 
(n = 234) 
P-value 
Age (years)  53.3 ± 9.5 55.6 ± 10.7    .018 
Gender (male) % 50.2 47.0    .497 
BMI (kg/m2) 32.8 ± 7.1 29.3 ± 4.8 < .001 
Smoke (yes) % 34.4 6.4 < .001 
Energy Intake (kcal/day) 1925 (1400) 1650 (1109) < .001 
Education (%)   < .001 
< Grade 8   1.9 31.6  
Some high school 13.4 14.5  
High school grad/GED 28.2 20.5  
Some college/technical school 38.3 17.1  
College graduate (bachelor’s degree) 11.0 12.0  
Graduate degree   7.2   4.3  
Data are median (interquartile range) or means ± SD unless otherwise indicated. BMI = 
body mass index. 
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Table 2 shows the comparison of the participants by diabetes status.  Participants 
with T2D were significantly older than participants without diabetes (M = 56.3 vs. M = 
52.7; p < .001) and had higher BMI (kg/m2) (M = 32.1 vs. M = 29.7; p < .001).  
Participants with T2D did not have lower calculated energy intake (kcal/day) (Md = 1681 
vs. Md = 1834; p = .052) than those without T2D, although the difference approached 
significance.  There were no differences in gender, percentage of smokers, or educational 
status for participants with and without T2D. 
The participants were also compared by both ethnicity and diabetes status using 
two-way ANOVA or non-parametric ANOVA (Table 3).  African Americans with T2D 
had significantly higher BMI (kg/m2) (M = 34.7) than African Americans without T2D 
(M = 30.6) and Haitian Americans with and without T2D (Ms = 29.6, 29.0, respectively).  
There were no significant differences for BMI in Haitian Americans with T2D compared 
to without T2D.   Haitian Americans with T2D had significantly lower energy intake 
(kcal/day) (M = 1430) than Haitian Americans without T2D (M = 1719), and both had 
significantly lower intakes than African Americans with and without T2D (Mds = 1857, 
2020, respectively).  Finally, a greater percent of Haitian Americans with T2D had less 
than grade 8 educations than those without T2D.  Thirty six percent of Haitian Americans 
with T2D had less than 8 years education compared with 26.5% of Haitian Americans 
without T2D and African Americans with and without T2D (3.6%, 0.0%, respectively). 
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Table 2 
General Characteristics of Participants by Diabetes Status 
 Diabetes  
Variables 
Yes 
(n = 233) 
No 
(n = 210) 
P-value 
Age (years)  56.3 ± 10.3 52.7 ± 9.8 < .001 
Gender (male) % 49.5 47.6   .692 
BMI (kg/m2) 32.1 ± 6.5 29.7 ± 5.7 < .001 
Smoke (yes) % 18.5 20.6    .591 
Energy Intake (kcal/day) 1681 (1306) 1834 (1382)    .052 
Education (%)      .072 
< Grade 8 14.2 20.6  
Some high school 11.4 16.3  
High school grad/GED 24.2 24.0  
Some college/technical school 28.5 25.7  
College graduate (bachelor’s degree) 13.3  9.8  
Graduate degree   8.1  3.4  
Data are median (interquartile range) or means ± SD unless otherwise indicated. BMI = 
body mass index. 
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Table 3 
General Characteristics of Participants by Ethnicity and Diabetes Status 
Data are median (interquartile range) or means ± SD unless otherwise indicated. Variables in the four groups with different 
superscripts are significantly different using Holm’s sequential Bonferroni post hoc test, p < .05. BMI = body mass index. 
                         Ethnicity African Americans Haitian Americans 
                                   Diabetes Status Yes No Yes No 
Variables (n = 112) (n = 97) (n = 121) (n = 113) 
Age (years)  54.8 ± 10.2b 51.7 ± 8.6a 57.6 ± 10.3b 53.5 ± 10.7a 
Gender (male) % 50.0 50.5 45.5 48.7 
BMI (kg/m2) 34.7 ± 7.1b   30.6 ± 6.4a  29.6 ± 4.8a 29.0 ± 5.0a 
Smoke (yes) %   35.7 b 33.0 b      6.6 a      6.2 a 
Energy Intake (kcal/day) 1857 (1457)c 2020 (1296)c 1430 (1150)a 1719 (1210)b 
Education (%)     
< Grade 8    3.6b    0.0 a  36.4 b   26.5 a 
Some high school 14.3 12.4 18.2 10.6 
High school grad/GED 28.6 27.8 19.8 21.2 
Some college/technical school 38.4 38.1 14.0 20.4 
College graduate (bachelor’s degree)  8.9 13.4 10.7 13.3 
Graduate degree  6.3  8.2  0.8   8.0 
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The participants were also compared by both ethnicity and diabetes status using 
two-way ANOVA or non-parametric ANOVA (Table 3).  African Americans with T2D 
had significantly higher BMI (kg/m2) (M = 34.7) than African Americans without T2D 
(M = 30.6) and Haitian Americans with and without T2D (Ms = 29.6, 29.0, respectively).  
Haitian Americans with T2D had significantly lower energy intake (kcal/day) (Md = 
1638) than Haitian Americans without T2D (Md = 1719), and both had significantly 
lower intakes than African Americans with and without T2D (Mds = 1857, 2020, 
respectively).  Finally, there was a greater percent of participants with T2D who had less 
than grade eight educations.  Thirty six percent of Haitian Americans with T2D had less 
than grade 8 education compared with 26.5% of Haitian Americans without T2D.  Four 
percent of African Americans with T2D had less than grade 8 education compared to 
0.0% without T2D. 
Biomarkers 
Table 4 shows glycemic control and oxidative stress biomarkers of participants by 
ethnicity.  African Americans had lower A1C levels (%) than Haitian Americans (M = 
6.7 vs. M = 7.1; p = .014).  African Americans had higher MnSOD levels (pg/ml) (M = 
2538 vs. M = 2016), and higher 8OHdG levels (pg/ml) (M = 1691 vs. M = 1626; p = 
.003) than Haitian Americans. 
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Table 4 
Biomarkers of Glycemic Control and Oxidative Stress of Participants by Ethnicity 
 Ethnicity 
Variables 
African 
Americans 
 (n = 209) 
Haitian 
Americans 
(n = 234) 
P‐value 
Fasting plasma glucose (mg/dl) 121.0 ± 51.2 129.1 ± 56.7    .117 
Hemoglobin A1C (%)   6.7 ± 1.5   7.1 ± 2.1    .014 
MnSOD (pg/ml)     2538.0 ± 1091.8  2015.8 ± 656.3 < .001 
Ln-MnSOD   7.7 ± 0.5   7.6 ± 0.3 < .001 
8OHdG (pg/ml) 1691.0 ± 225.1 1626.2 ± 222.9    .003 
MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-hydroxy-2”-deoxyguanosine; 
Ln-MnSOD = Natural logarithm of Manganese Superoxide Dismutase.  
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Biomarkers of glycemic control and oxidative stress of participants were 
compared by diabetes status as shown in Table 5.  Participants with T2D had higher 
fasting plasma glucose (mg/dl) and A1C levels (%), had lower MnSOD levels (pg/dl), 
and higher 8OHdG levels (pg/dl) than subjects without T2D.  
The participants were also compared by both ethnicity and diabetes status as 
shown in Table 6.  Haitian Americans with T2D had significantly higher fasting plasma 
glucose (mg/dl) (M = 158) than African Americans with T2D (M = 143), and both had 
significantly higher fasting plasma glucose than African Americans and Haitian 
Americans without T2D (Ms = 96, 99, respectively).  Similarly, Haitian Americans with 
T2D had significantly higher A1C levels (%) (M = 8.4) than African Americans with 
T2D (M = 7.5), and both had significantly higher A1C levels than African Americans and 
Haitian Americans without T2D (Ms = 5.9, 6.0, respectively).   
African Americans without T2D had the highest MnSOD levels (pg/ml) (M = 
3541) of the four groups, Haitian Americans with T2D had the second highest MnSOD 
levels (M = 2174), Haitian Americans without T2D had the next highest MnSOD levels 
(M = 1846), and African Americans without T2D had the lowest MnSOD levels (M = 
1669).  These differences were all significant. 
 The serum levels of 8OHdG (pg/ml) in African Americans with T2D were 
significantly higher (M = 1796) than those of the other three groups.  Haitian Americans 
with T2D had significantly higher levels of 8OHdG (M = 1735) than African Americans 
without T2D and Haitian Americans without T2D (Ms = 1570, 1510, respectively). 
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Table 5 
Biomarkers of Glycemic Control and Oxidative Stress of Participants by Diabetes Status 
 Diabetes 
Variables 
Yes 
(n = 233) 
No 
(n = 210) 
P-value 
Fasting plasma glucose (mg/dl) 150.5 ± 63.7   97.4 ± 15.3 < .001 
Hemoglobin A1C (%)   7.9 ± 2.1   5.9 ± 0.4 < .001 
MnSOD (pg/ml)      1931.6 ± 630.1   2628.9 ± 1054.8 < .001 
Ln-MnSOD  7.5 ± 0.3   7.8 ± 0.4 < .001 
8OHdG (pg/ml)      1764.2 ± 188.6 1537.6 ± 203.5 < .001 
MnSOD= Manganese Superoxide Dismutase; 8OHdG= 8-hydroxy-2”-deoxyguanosine; 
Ln-MnSOD = Natural logarithm of Manganese Superoxide Dismutase. 
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Table 6 
Biomarkers of Participants by Ethnicity and Diabetes Status 
                                Ethnicity African Americans Haitian Americans 
                               Diabetes 
Status 
Yes No Yes No 
Variables (n = 112) (n = 97) (n = 121) (n = 113) 
Fasting plasma glucose (mg/dl)   143.0 ± 61.0b     95.8 ± 13.2a   157.6 ± 65.5c     98.7 ± 16.9a 
Hemoglobin A1C (%)     7.5 ± 1.8b     5.9 ± 0.4a     8.4 ± 2.4c     6.0 ± 0.5a 
MnSOD (pg/ml) 1669.3 ± 521.3d 3541.1 ± 609.4a 2174.4 ± 626.7b 1845.9 ± 647.3c 
Ln-MnSOD    7.4 ± 0.3a    8.2 ± 0.2d    7.6 ± 0.3c    7.5 ± 0.3b 
8OHdG (pg/ml)  1795.9 ± 194.7c  1569.9 ± 196.0a  1735.0 ± 178.7b  1509.8 ± 206.5a 
Variables in four groups with different superscript are significantly different using Holm’s sequential Bonferroni post hoc test, 
p < .05.  MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-hydroxy-2”-deoxyguanosine; Ln-MnSOD = Natural 
logarithm of Manganese Superoxide Dismutase.   
 54 
 
Macro and Micronutrients 
 Table 7 presents the macro and micronutrient intake of participants by ethnicity. 
Non-parametric tests were conducted on all variables, since all were non-normally 
distributed, so results were reported with median and interquartile range (IQR).  African 
Americans had significantly higher median calculated energy intake (kcal/day) (1925 vs. 
1650; p < .001), protein intake (g/day) (76.6 vs. 62.4; p < .001), fat intake (g/day) (72.4 
vs. 45.3; p < .001), vitamin D intake (IU/day) (455.6 vs. 268.7; p < .001), vitamin E 
intake (IU/day) (11.0 vs. 7.9; p = .004), and zinc intake (mg/day) (12.6 vs. 9.0; p < .001) 
than Haitian Americans. Conversely, Haitian Americans had a significantly higher 
median intake of fiber (g/day) (24.1vs.17.0; p < .001) and carotenoids (IU/day) (11864 
vs. 5636; p < .001) than African Americans. 
Table 8 presents the macro and micronutrients intake of participants by diabetes 
status.   Subjects with T2D had a significantly lower median carbohydrate intake (g/day) 
(225.4 vs. 257.6; p = .012), vitamin E intake (IU/day) (8.1 vs. 10.7; p = .030), and 
vitamin C intake (IU/day) (156.0 vs. 201.2; p = .002) than subjects without T2D. 
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Table 7 
Macro and Micronutrients Intake of Participants by Ethnicity 
 Ethnicity  
Variables 
African Americans 
 (n = 209) 
Haitian Americans 
(n = 234) 
P‐value 
Energy Intake (kcal/day) 1924.8 (1400.0) 1649.9 (1109.0) < .001 
Protein intake (g/day) 76.6 (54.7) 62.4 (46.4) < .001 
Carbohydrate intake (g/day) 249.0 (192.8) 229.9 (165.0)    .107 
Fat intake (g/day) 72.4 (53.4) 45.3 (40.6) < .001 
Fiber intake (g/day) 17.0 (15.8) 24.1 (19.6) < .001 
Vitamin E  (IU/day) 11.0 (17.6) 7.9 (10.5)    .004 
Vitamin D (IU/day) 455.6 (498.9) 268.7 (384.2) < .001 
Vitamin C (mg/day)  174.1 (221.0) 175.3 (191.6)    .938 
Manganese (mg/day) 3.4 (3.1) 4.5 (3.2)    .009 
Carotenoids (IU/day) 5635.7 (8240.0) 11864.4 (13762.3) < .001 
Zinc (mg/day) 12.6 (12.0) 9.0 (7.2) < .001 
Data are expressed as median (interquartile range). 
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Table 8 
Macro and Micronutrients Intakes of Participants by Diabetes Status 
 Diabetes  
Variables 
Yes 
(n=233) 
No 
(n=210) 
P-value 
Energy Intake (kcal/day) 1680.7 (1306.0) 1834.1(1382.0)  .052 
Protein intake (g/day) 68.5 (50.0) 69.9 (48.6)  .823 
Carbohydrate intake (g/day) 225.4 (173.4) 257.6 (172.3)  .012 
Fat intake (g/day) 54.1 (46.8) 57.6 (54.1)  .406 
Fiber intake (g/day) 20.3 (17.6) 21.3 (19.2)  .294 
Vitamin E  (IU/day) 8.1 (11.5) 10.7 (16.5)  .030 
Vitamin D (IU/day) 325.8 (431.5) 355.9 (509.1)  .052 
Vitamin C (mg/day)  156.0 (181.2) 201.2 (241.7)  .002 
Manganese (mg/day) 3.7 (3.1) 3.9 (3.1)  .334 
Carotenoids (IU/day) 7153.0 (10132.5) 8435.4 (12374.0)  .214 
Zinc (mg/day) 9.8 (10.0) 10.7 (10.2)  .376 
Data are expressed as median (interquartile range).   
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Energy intakes of participants by ethnicity and diabetes status 
The participants were compared on the macro and micronutrient intake by 
ethnicity and diabetes status using non-parametric ANOVA (Table 9).  As seen in Table 
3, Haitian Americans with T2D had significantly lower energy intake (kcal/day) (Md = 
1430) than Haitian Americans without T2D (Md = 1719), and both had significantly 
lower intakes than African Americans with and without T2D (Mds = 1857, 2020, 
respectively).    
Protein, Carbohydrate, and Fat Intakes by ethnicity and diabetes status 
Haitian Americans with T2D had a significantly lower median carbohydrate 
intake (g/day) (206.3) than Haitian Americans without T2D (253) and African Americans 
with and without T2D (236.6, 259.8, respectively). 
Vitamin and Mineral Intakes by ethnicity and diabetes status 
Haitian Americans with T2D had a significantly lower median vitamin E intake 
(IU/day) (7.3) than the other three groups.  In addition, Haitian Americans without T2D 
(9.5) and African Americans with T2D (10.4) had significantly lower median vitamin E 
intakes than African Americans without T2D (12.3). 
Haitian Americans with T2D had a significantly lower median vitamin D intake 
(IU/day) (236.4) than the other three groups.  Haitian Americans without T2D had a 
significantly lower median vitamin D intake (280.5) than African Americans with and 
without T2D (371.8, 471.7, respectively).  
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Haitian Americans with T2D had a significantly lower median vitamin C intake 
(mg/day) (138.4) than Haitian Americans without T2D (203.9) and African Americans 
with and without T2D (165.6 and 198.1, respectively). 
Haitian Americans without T2D had a higher median manganese intake (mg/day) 
(4.4) than the other three groups.  Median intakes for Haitian Americans with T2D was 
4.1 mg/day, for African American without T2D (3.4), and for African Americans with 
T2D (3.3).   
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Table 9  
Macro and Micronutrients Intake of Participants by Ethnicity and Diabetes Status 
 
Data are expressed as median (interquartile range). Variables in groups with different superscripts are significantly different 
using Holm’s sequential Bonferroni post hoc test, p < .05.   
                                     Ethnicity African Americans Haitian Americans 
                                     Diabetic Status Yes No Yes No 
Variables (n = 112) (n = 97) (n = 121 (n = 113) 
Energy Intake (kcal/day) 1857 (1457)c 2020 (1296)c 1430 (1150)a 1719 ( 1210)b 
Protein intake (g/day) 75.9 (58.6)b 79.4 (56.4)b 60.1 (51.8)a 63.5 (42.9)a 
Carbohydrate intake (g/day) 236.6 (210.0)b 259.8 (171.6)b 206.3 (145.8)a 253.4 (174.5)b 
Fat intake (g/day) 70.0 (58.0)b 73.5 (49.5)b 41.9 (41.4)a 46.4 (41.2)a 
Fiber intake (g/day) 16.6 (13.6)a 18.3 (17.1)a 22.4 (18.8)b 25.2 (21.1)b 
Vitamin E  (IU/day) 10.4 (15.7)b 12.3 (19.4)c 7.3 (8.8)a 9.5 (11.4)b 
Vitamin D (IU/day) 371.8 (472.7)c 471.7 (569.9)c 236.4 (380.3)a 280.5 (425.5)b 
Vitamin C (mg/day) 165.6 (208.3)b 198.1 (260.3)b 138.4 (170.0)a 203.9 (237.2)b 
Manganese (mg/day) 3.3 (3.1)a 3.4 (3.4)a 4.1 (3.2)a 4.4 (2.9)b 
Carotenoids (IU/day) 5618.8 (7236.7)a 5644.1 (9472.6)a 11368.3 
(13612.3)b 
12162.4 
(14915.2)b 
Zinc (mg/day) 12.2 (12.2)b 13.0 (11.9)b 9.0 (7.8)a 9.0 (6.8)a 
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Section 2:  Correlations 
Correlation of Oxidative Stress Biomarkers and Socio-demographic 
Characteristics 
This section contains results of the correlation analysis between 
biomarkers and socio-demographics using Pearson’s and point bi-serial 
correlations, depending on the type of socio-demographic variable.  The 
associations between Ln-MnSOD and 8OHdG levels and dietary antioxidant 
intakes were analyzed with Pearson’s correlations.  Additionally, Pearson’s and 
point bi-serial correlations measured the relationship between glycemic control 
with socio-demographic variables and dietary antioxidant intakes for study 
participants with T2D.  Overall, there was a significant negative correlation 
between Ln-MnSOD and 8OHdG, r = - .17, p < .001, so that lower levels of Ln-
MnSOD associated with higher levels of 8OHdG. 
Correlation of Oxidative Stress Biomarkers and Study Variables 
 Table 10 presents the Pearson’s correlation analysis of oxidative stress 
biomarkers with study variables.  Ln-MnSOD was negatively correlated with 
BMI, r = - .15, p < .05, and 8OHdG was positively correlated with BMI, r = - 
.15, p < .05, age, r = .13, p < .01, and being male, r = .11, p < .05.  Thus, lower 
levels of Ln-MnSOD were associated with greater BMI, while higher levels of 
8OHdG were associated with greater BMI, being older and being male. 
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Table 10 
Pearson’s Correlations of Oxidative Stress Biomarkers with Study Variables 
 Participants (n = 433)  
Variables MnSOD       Ln-MnSOD        8OHdG
Age (years)    -.10*    -.09             .13** 
Gender (male)   .07     .06  .11* 
BMI (kg/m2)    -.15**    -.15**             .15** 
Smoke (yes)    .10*     .07 .04 
Energy Intake(kcal/day)  .04     .02   -.05 
Education  .08     .07  .01 
Less than high school  -.11*    -.10* -.03 
High school grad/GED  .07     .07  .04 
Some college/technical school   .07     .06 -.01 
Graduate school   -.02    -.02 .00 
* p < .05, ** p < .01 
BMI = body mass index; MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-
hydroxy-2”-deoxyguanosine. Ln-MnSOD = Natural logarithm of Manganese 
Superoxide Dismutase. 
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Table 11 presents Pearson’s correlation analysis of oxidative stress 
biomarkers with dietary antioxidants intakes.  Lower levels of Ln-MnSOD were 
associated with lower levels of zinc, r = .10, p < .05, and higher levels of 
carotenoids, r = -.10, p < .05.  Higher levels of 8OHdG were associated with 
lower levels of Vitamin D, r = -.14, p < .01, and carotenoids, r = -.09, p < .05. 
 Table 12 presents Pearson’s correlation analysis of glycemic control with 
socio-demographic variables and dietary antioxidant intakes for study 
participants with T2D.  Diabetic participants with higher FPG had lower intakes 
of Vitamin D, r = -.14, p < .05.  Higher A1C levels in T2D participants were 
associated with being Haitian, r = -.19, p < .01, and having less education, r = -
.14, p < .05. 
In addition, for Haitian Americans with T2D, higher FPG levels were 
associated with lower BMI, r = -.25, p < .01, and lower Vitamin C intakes, r = -
.19, p < .05.  For African Americans with T2D, higher FPG levels were 
associated with higher Vitamin E intakes, r = -.25, p < .01.  Higher A1C levels 
were associated with lower carotenoids intakes, r = -.19, p < .05, for this group. 
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Table 11 
Pearson’s Correlations of Oxidative Stress Biomarkers with Study Variables 
  Participants (n = 433)  
Variables  MnSOD LnMnSOD  8OHdG
Energy Intake (kcal/day)   .04  .02 -.05 
Vitamin E / 1000 kcal/day -.00 -.01  .01 
Vitamin D / 1000 kcal/day  .08  .07 -.02 
Vitamin C / 1000 kcal/day  .06  .07     -.14** 
Manganese / 1000 kcal/day -.06          -.03  .00 
Carotenoids / 1000 kcal/day  -.11* -.10*   -.09* 
Zinc / 1000 kcal/day  .10*  .10*   .00 
* p < .05, ** p < .01 
BMI = body mass index; MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-
hydroxy-2”-deoxyguanosine. Ln-MnSOD = Natural logarithm of Manganese 
Superoxide Dismutase. 
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Table 12 
Pearson’s Correlations of Glycemic Control with Study Variables in Individuals with 
T2D 
 
    Glycemic Control 
      (n = 433)  
  
Variables     FPG  A1C   
Ethnicity (African American)     -.12     -.19**   
Age (years)      -.04  -.10   
Gender (male)       .07   .06   
BMI (kg/m2)     -.12  -.07   
Smoke (yes)     -.04  .01   
Energy Intake(kcal/day)     -.06  -.09   
Education      -.10  -.14*   
Less than high school      .09  .13   
high school grad/GED     -.01  -.04   
some college/technical school     -.03  -.04   
graduate school       -.08  -.08   
Vitamin E / 1000 kcal      .11  -.01   
Vitamin D / 1000 kcal      -.14*  -.02   
Vitamin C / 1000 kcal     -.07  -.05   
Manganese / 1000 kcal     .01  .04   
Carotenoids / 1000 kcal     .04  .02   
Zinc/1000 kcal        -.04     -.05   
* p < .05, ** p < .01 
A1C = glycosylated hemoglobin; FPG = fasting plasma glucose; BMI = body mass 
index.  
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Section 3:  Hypotheses Testing 
 
Hypothesis testing was conducted with Analysis of Covariance 
(ANCOVA), and multiple linear regression analysis. We compared the levels of 
MnSOD and 8OHdG by ethnicity and diabetes status using ANCOVAs.  Post 
hoc test using Fisher’s LSD procedure were carried out on the adjusted ethnic 
and diabetes status means for significant tests of interaction.  
Relationships of MnSOD and 8OHdG with dietary antioxidants by 
ethnicity and diabetes status were analyzed by multiple linear regression 
analyses.  The relationships between glycemic controls (A1C) and fasting plasma 
glucose levels (FPG) with dietary antioxidants by ethnicity and diabetes status 
were determined with multiple linear regression analyses.  The covariates for all 
analyses were age, gender, smoking status, education, BMI, and energy intake.  
Aim 1.  To determine the differences in serum MnSOD and 8OHdG by 
diabetes status and ethnicity. 
 
Hypothesis 1a:  Serum levels of MnSOD will be lower in participants with 
T2D as compared to those without T2D, independent of ethnicity 
 
ANCOVA on Manganese Superoxide Dismutase (MnSOD) 
In a two way ANCOVA on Ln-MnSOD by ethnicity (Haitian, African 
American) and diabetes status (yes/no), both main effects were significant, 
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ethnicity, F(1,433) = 55.46, p < .001, ƞ2 = .11, diabetes status, F(1,433) = 
108.57, p < .001, ƞ2 = .20.  However, the main effects were moderated by 
significant interaction of ethnicity by diabetes status, F(1,433) = 293.43, p < 
.001, ƞ2 = .40.  By convention, a “small” effect is ƞ 2 = .01, a “medium” effect is 
ƞ 2 = .06, and a “large” effect is ƞ 2 = .16.  These effects were all very large.  The 
adjusted mean Ln-MnSOD for African Americans without diabetes (M = 8.16) 
was significantly larger than for African Americans with diabetes (M = 7.40) and 
for Haitian Americans with and without diabetes (M = 7.63; M = 7.46, 
respectively). 
Hypothesis one was not supported.  Although African Americans with 
diabetes had lower MnSOD levels than African Americans without diabetes, this 
was not the case for Haitian Americans, so lower serum levels of MnSOD in 
T2D participants was not independent of ethnicity. 
Hypothesis 1b:  Serum levels of 8OHdG will be higher in participants with 
T2D when compared to without T2D, independent of ethnicity. 
 
ANCOVA on mtDNA 8-hydroxy-2’-deoxyguanosine (8OHdG)  
In a two way ANCOVA on 8OHdG by ethnicity and diabetes status, both 
main effects were significant, ethnicity, F(1, 433) = 6.44, p = .012, ƞ2  = .02, 
diabetes status F(1,433) =126.38, p < .001, ƞ 2 = .23.  There was not a significant 
interaction effect, F(1,433) = .05, p = .826, ƞ 2 < = .01. 
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In support of Hypothesis 1b, the adjusted 8OHdG mean (M = 1761.36) 
for individuals with diabetes was significantly higher than those without diabetes 
(M = 1544.11), independent of ethnicity.  Additionally, the adjusted 8OHdG 
mean for African Americans (M = 1680.47) was significantly higher than for 
Haitian Americans (M =1625.00).  
Hypothesis 1c:  There will be an inverse relationship between serum levels 
of MnSOD and 8OHdG in participants with T2D, independent of ethnicity. 
 
Multiple Linear Regression of MnSOD with 8OHdG 
The multiple regression analysis of 8OHdG on MnSOD with control 
variables of ethnicity, diabetes status, age, gender, smoking status, education, 
BMI, and energy intake was significant, R2 = 29.6%, F(10,433) = 18.15, p < 
.001.  However, MnSOD did not explain significant additional variability of 
8OHdG, R2 change = 0.3%, F(1,432) = 2.14, β = -.09,  p = .145.   In the final 
model, significant covariates were:  having T2D, β = .51, p < .001, being male, β 
= .14, p = .002, and being African American, β = .22, p = .011. 
Hypothesis 1c was not supported in that the data did not show an inverse 
relationship between the serum levels of MnSOD and 8OHdG in African 
Americans and Haitian Americans with T2D. 
Aim 2:  To determine the relationships of serum MnSOD and 8OHdG with 
various dietary antioxidants by diabetes status and ethnicity. 
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Hypothesis 2a:  Serum 8OHdG levels will be negatively associated with 
dietary intake of antioxidants, independent of diabetes status and ethnicity. 
 
Multiple Linear Regression of 8OHdG on dietary intake of antioxidants 
Multiple linear regression analysis showed that vitamin C intake per 1000 
kcal explained significant additional variability of 8OHdG, R2 change = 0.8%, 
F(1,432) = 5.25, β = - .10, p = .022.  In this model, lower levels of 8OHdG were 
associated with higher vitamin C levels after controlling for age, gender, 
smoking status, education, BMI, energy intake, ethnicity, diabetes status and the 
interaction between ethnicity and diabetes status.  Significant covariates were: 
having type 2 diabetes, β = .48, p < .001; being African American, β = .13, p = 
.034; the interaction between having type 2 diabetes and African American, β = - 
.14, p < .001; and being male, β = .12, p < .005.  
Vitamin D intake per 1000 kcal did not explain significant additional 
variability of 8OHdG, R2 change = 0.0%, F(1,432) = 0.10, β = .01, p = .922.  
Significant covariates were:  having type 2 diabetes, β = .49, p < .001; being 
male, β = .13, p = .002; and being African American, β = .13, p = .037. 
 Vitamin E intake per 1000 kcal did not explain significant additional 
variability of 8OHdG, R2 change = 0.0%, F(1,432) = 0.80, β = .01, p = .927.  
Significant covariates were: having type 2 diabetes, β = .49, p < .001; being 
male, β = .13, p = .003; and being African American, β = .13, p = .035. 
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 Carotenoids intake per 1000 kcal did not explain significant variability of 
8OHdG, R2 change = 0.2%, F(1,432) = .975, β = - .04, p = .324.  Significant 
covariates were: having type 2 diabetes, β = .49, p < .001; and being male, β = 
.13, p = .003. 
 Hypothesis 2a was supported for vitamin C, but not for vitamin D, E, or 
carotenoids. 
Hypothesis 2b:  MnSOD levels will be negatively associated with dietary 
intake of antioxidants, independent of diabetes status and ethnicity. 
 
Multiple linear regression analysis on MnSOD on dietary intake of 
antioxidants 
Vitamin C intake per 1000 kcal did not explain significant additional 
variability of ln-MnSOD, R2 change = 0.2%, F(1, 432)= 1.90, p = .169. 
Significant covariates were being African American, β = .878, p < .001, having 
diabetes, β = .22, p <.001, and interaction between ethnicity and diabetes status, 
β= -1.01, p < .001.   
Vitamin D intake per 1000 kcal did not explain significant additional 
variability of ln-MnSOD, R2 change = 0.0%, F(1, 432)= .294, p = .588. 
Significant covariates were being African American, β = .872, p < .001, having 
diabetes, β = .215, p < .001, and interaction between ethnicity and diabetes status 
β = -1.007, p < .001. 
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Vitamin E intake per 1000 kcal did not explain significant additional 
variability of ln-MnSOD, R2  change = 0.1%,  F(1,432) = .879,  p = 0.349. 
Significant covariates were being African American, β = .88, p < .001, having 
diabetes, β = .21, p < .001, and the interaction between African American and 
diabetes status, β = -1.01, p < .001.  
 Carotenoids intake per 1000 kcal did not explain significant additional 
variability of ln-MnSOD, R2 change = 0.1%, F(1, 432)= 1.268, p = .261. 
Significant covariates were being African American, β = .863, p < .001, having 
diabetes, β = .215, p < .001, and interaction between ethnicity and diabetes 
status, β = -1.009, p < .001. 
Hypothesis 2b was not supported for any of the antioxidants, vitamin C, 
D, E or carotenoids. 
Aim 3:  To examine the relationships of glycemic control (A1C) and fasting 
plasma glucose level with dietary antioxidants in T2D by ethnicity. 
 Control variables for the multiple regression analyses were: ethnicity, 
age, gender, education, energy intake, BMI, and smoking status.  Only diabetic 
participants were included in these analyses. 
Haitian Americans with T2D had significantly higher fasting plasma 
glucose (mg/dl) (M = 158) than African Americans with T2D (M = 143), and 
similarly, Haitian Americans with T2D had significantly higher A1C levels (%) 
(M = 8.4) than African Americans with T2D (M = 7.5), (Table 6). 
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Hypothesis 3a: There will be no relationship between serum A1C and any 
dietary antioxidants in participants with T2D independent of ethnicity. 
 
Multiple Linear Regression of Hemoglobin A1C (A1C) 
Vitamin C intake per 1000 kcal did not explain significant additional 
variability of A1C, R2 change = 0.0%, F(1,432) = .27,  = .04, p = .601.  The 
significant covariates was being African American, β = -.19, p = .023. 
The multiple regression analysis of A1C on vitamin D was not 
significant, R2 = 6.9%, F(8, 224) = 2.09, p =  .995.   Vitamin D did not explain 
significant additional variability in the model, R2 change = 0.0%, β = -.01, p = 
.905.  The significant covariate was being African American, β = -.20, p = .020. 
  The multiple regression analysis of A1C on vitamin E, was not 
significant, R2 = 6.9%, F(8, 224) = 2.09, p = .943.   Vitamin E did not explain 
significant additional variability in the model, R2 change = 0.0%, β = .01, p = 
.943.  The significant covariate was being African American, β = - .20, p = .020. 
  The multiple regression analysis of A1C on carotenoids, was not 
significant, R2 = 6.9%, F(8, 224) = 2.09, p = .685.   Carotenoids did not explain 
significant additional variability in the model, R2 change = 0.0%, β = .04, p = 
.604.  The significant covariate was being African American,  β = - .12, p = .045.  
Hypothesis 3a was supported since A1C was not related to any of the 
antioxidants, vitamin C, D, E or carotenoids, for T2D participants. 
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Hypothesis 3b: There will be no relationship between fasting plasma glucose 
level and any of the dietary antioxidant intakes in T2D independent of 
ethnicity. 
 
Multiple regression analysis of fasting plasma glucose (FPG) 
The multiple regression analysis of FPG on vitamin C per 1000 kcal was not 
significant, R2 = 4.1%, F(8,224) = 1.20, p = .302.  Vitamin C intake did not 
explain significant additional variability of FPG, R2 change = 0.1%, F(1,432) = 
1.17, β = -.07, p = .280.  The significant covariate was being African American, 
β = -.19, p = .023. 
The multiple regression analysis of FPG on vitamin D per 1000 kcal was not 
significant, R2 = 5.3%, F(8,224) = 1.57, p = .135. Vitamin D intake per 1000 kcal 
explained significant additional variability of FPG, R2 change = 1.7%, F(1,432) 
= 4.05 , β = -.13, p = .045. The significant covariate was being African 
American, β = - .20, p = .020.  
The multiple regression analysis of FPG on vitamin E intake per 1000 kcal 
was not significant, R2 = 4.9%, F(8,224) = 1.44, p = .183. Vitamin E intake did 
not explain significant additional variability of FPG, R2 change = 1.3%,  
F(1,432) = 3.11 , β = .11, p = .084. The significant covariate was being African 
American, β = -.19, p = .023. 
The multiple regression analysis of FPG on carotenoids intake per 1000 kcal 
was not significant, R2 = 3.7%, F(8,224) = 1.07, p = .388.  Carotenoids did not 
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explained significant additional variability of FPG, R2 change = 1.9%, F(1,432) 
= 2.09 , β = -.14, p = .083.  
Hypothesis 3b was supported since fasting plasma glucose was not 
significantly related to any of the antioxidants, vitamins C, D, E, or carotenoids 
for T2D participants. 
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Table 13 
 Results of Hypothesis Testing 
HYPOTHESIS RESULTS  
H1a:  Serum levels of MnSOD will be lower 
in participants with T2D as compared to those 
without T2D, independent of ethnicity. 
Hypothesis 1a was not supported.  
Although African Americans with 
diabetes had lower MnSOD levels 
than African Americans without 
diabetes, this was not the case for 
Haitian Americans, so lower serum 
levels of MnSOD in T2D participants 
was not independent of ethnicity. 
 
H1b:  Serum levels of 8OHdG will be higher 
in participants with T2D when compared to those 
without T2D, independent of ethnicity. 
Hypothesis 1b was supported since 
the adjusted serum levels of 8OHdG 
mean for individuals with diabetes 
was significantly higher than for those 
without diabetes, independent of 
ethnicity.  Also, adjusted 8OHdG 
mean for African Americans was 
significantly higher than for Haitian 
Americans. 
H1c:  There will be an inverse relationship 
between serum levels of MnSOD and 8OHdG 
in participants with T2D, independent of ethnicity. 
 
Hypothesis 1c was not supported by 
the findings in this study. 
H2a:  Serum 8OHdG levels will be  
negatively associated with dietary intake of 
antioxidants, independent of diabetes status 
and ethnicity. 
 
Hypothesis 2a was not supported for 
vitamin C since multiple linear 
regression analysis showed that 
vitamin C intake per 1000 kcal 
explained significant additional 
variability of 8OHdG,  R2 change = 
0.8%, β = -0.10, p = .022 
 
H2b:  Serum MnSOD levels will be negatively  
associated with dietary intake of antioxidants, 
independent of diabetes status and ethnicity. 
Hypothesis 2b was not supported 
since multiple regression analysis 
showed that none of the 
antioxidants, vitamins C, D, E or 
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carotenoids, were significant in 
explaining the variability of Ln-
MnSOD.     
  
H3a:  There will be no relationship between 
 serum A1C and dietary antioxidants in 
participants with T2D independent of ethnicity. 
 
Hypothesis 3a was supported since 
serum A1C was not related to any 
of the antioxidants in the multiple 
regression analyses on T2D 
participants.   
H3b:  There will be no relationship between 
fasting serum glucose level and any of the 
dietary antioxidant intakes in T2D independent 
 of ethnicity. 
Hypothesis 3b was supported 
since fasting plasma glucose was 
not related to any of the 
antioxidants in the multiple 
regression analyses on T2D 
participants. 
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 CHAPTER V 
 DISCUSSION 
This chapter presents the discussion of the results.  It is organized as 
follows:  First, the descriptive statistics of the participants’ general 
characteristics and socio-demographic status; Secondly the interpretation and 
qualitative analysis are discussed in the order which the aims and hypothesis 
were presented in this study.  Finally, the study strengths and limitations, 
conclusions, and recommendations for future studies are provided. 
 Researchers and healthcare practitioners recognize that there are ethnic 
differences and disparities in many health disorders.  It has been reported that 
blacks have a higher incidence of diabetes and diabetes related complications 
(Huffman et al., 2013) than whites, and there is an increasing awareness of ethnic 
group differences among subgroups normally grouped together as blacks.  Two 
such subgroups are African Americans and Haitian Americans, both of whom 
were examined in this research study. 
General Characteristics of Participants 
African Americans are affected by diabetes disproportionately as 
compared to the general population.  They are 1.8 times more likely to have 
diabetes and also more likely to develop diabetes complications such as kidney 
disease, blindness and cardiovascular disease when compared with whites (ADA, 
2013).  The prevalence of having diabetes in African Americans was determined 
to be 18.7 percent (ADA, 2013).  Often time poor dietary patterns correlate with 
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poor health, and the traditional diet of African Americans called “soul food” has 
been reported as being a poor diet, consisting of southern style foods which 
include pork chops and fried fatty foods (Anderson-Loftin et al., 2005).   
The culture of Haitian Americans may explain the differences in study 
variables when compared with African Americans (“Background on Haiti”, 
2010).  Haitian Americans resistance to healthcare screening may relate to their 
mistrust of healthcare providers.  This under-utilization of health care resources 
may result in undiagnosed or untreated cardiovascular disease and T2D.  
According to a report by Huffman et al. (2013), although the diet of Haitian 
Americans is healthier than African Americans, it is not necessarily a healthy 
diet. The researchers reported that African American diet consisted of high fat 
content as compared with Haitian Americans whose diet consisted of fish, 
chicken, fruits and vegetables.  African Americans scored lower than Haitian 
Americans using the Health Eating Index, indicating that Haitian Americans had 
a healthier diet than African Americans.  The components of a high fat diet 
include hydrogenated oils, animal fats, free fatty acids, which are found in 
African Americans and may contribute to an increase risk of T2D and this type 
of dietary pattern may lead to increased oxidative stress (Watters, et al., 2007). 
The information on the general characteristics of the respective diets for 
the study participants were obtained from a FFQ completed by the participants 
and from physiologic biometrics recorded by trained research assistants.  In this 
study, African American participants were generally younger, had higher BMI, 
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higher energy intakes, were more educated, and had a greater percentage of 
smokers than Haitian Americans (Table 1).  There were similar numbers of male 
and female participants for both ethnicities.  The data obtained from the FFQ 
show higher energy intakes observed in African Americans which explains the 
higher BMI compared with Haitian Americans. 
 The characteristics of participants by diabetes status are shown in Table 
2.  Participants with T2D had higher BMI (32.1 kg/m2 ± 6.5) compared with 
participants without T2D (29.7 kg/m2 ± 5.7).  The average BMI of participants 
without T2D were within the range classified as overweight and those with T2D 
were classified as obese.  Since the participants without T2D were classified as 
overweight, they also have an increased risk for diabetes (Sanada et al., 2012).  
These findings complement those reported by other researchers (Wee et al., 
2008) who used data obtained from the 1999-2004 National Health and Nutrition 
Examination Survey (NHANES).   
 The participants with T2D had lower energy intake when compared to 
participants without T2D.  The lower energy intake in participants with T2D may 
be explained by low calorie diets which are normally prescribed by healthcare 
practitioner as part of a treatment program.  It is well documented  that there is a 
strong positive association between energy intake with insulin resistance (Donin 
et al., 2013) and that weight loss is central to glycemic control improvement 
(Looker et al., 2001).  Additionally, the low energy intake may be a result of 
under-reporting or due to false perception of food portion sizes and 
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misrepresentation of actual intake (Samuel-Hodge et al. 2004).   Olendzki et al. 
(2014) reported similar findings about under-reporting and they observed that the 
prevalence of under-reporting in a Caribbean Latino population studied was 
related to BMI, gender, and educational level.  In this study, if the total energy 
intake calculated from the FFQ was <500 kcal per day or >5000 kcal per day, 
then the data was not included in the analysis.  Similar cutoffs were reported by 
Hebert et al. (2002) as a common means to exclude reporting errors and extreme 
values. 
Biomarkers 
There are many assays developed to quantify oxidative stress, including 
the measure of oxidation of proteins, lipids, DNA, and antioxidant enzymes.  The 
focus of this study is blood antioxidant enzyme manganese superoxide dismutase 
(MnSOD) and the byproduct of mtDNA damage known as 8-hydroxy-2’-
deguanosine (8OHdG). These variables were studied because of their 
localization and interaction in the mitochondria, and also because of their 
participation in the T2D associated progressive disorders (Kirk at al., 2006; 
Feairheller et al., 2011).  The relationship between oxidative stress and diabetes 
status was examined because the literature review has shown that reactive 
oxygen species also influences the glycemic control (Kirk at al., 2006; 
Feairheller et al., 2011).  In addition to elevated reactive oxygen species, the 
literature presented evidence that there is a direct correlation with elevated levels 
of oxidative stress biomarkers. 
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Glycemic control can be determined with the blood biomarkers FPG and 
A1C (ADA, 2013).  This study examined serum levels of oxidative stress 
biomarkers and glycemic control indicators and provided data on macro and 
micronutrients intakes obtained from food frequency questionnaire.  The 
relationship of serum levels of manganese superoxide dismutase and mtDNA 8-
hydroxy-2’-deoxyguanosine were examined.  In addition, the relationship when 
compared with dietary antioxidants intake in T2D in African Americans and 
Haitian Americans, two different ethnic groups, were determined. 
An intensive literature search showed limited amount of data on the 
differences within minority groups.  This study provided information of 
differences on serum levels of MnSOD and 8OHdG among African Americans 
and Haitian Americans.  In addition, this report is the first cross sectional study 
that examined the relationship of oxidative stress biomarkers among African 
Americans and Haitians with and without T2D.  
The aim of this study was to examine the serum levels of 8OHdG, the 
surrogate biochemical marker for mtDNA damage, and MnSOD which is the 
body’s primary antioxidant enzyme that protects the DNA in the mitochondria.   
We also investigated their relationship to dietary antioxidant intakes and 
glycemic control.  Previous studies (Arab at al., 2011; Kirk at al., 2006; 
Feairheller et al., 2011) reported differences between African Americans and 
whites for glycemic control, oxidative stress biomarkers, and dietary 
antioxidants.    Kirk et al. found ethnic disparities in glycemic control in African 
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Americans and Non-Hispanic White adults with diabetes and reported that the 
cause of disparity may be related to the access to medical care and the amount of 
dietary antioxidants consumed.  In this study, differences were found in glycemic 
control and dietary antioxidants intakes between African Americans and Haitian 
Americans.  While access to medical care and attendance of doctor’s visits was 
not a part of this project, these variables may have played a role.  The findings of 
this study show significantly higher levels of 8OHdG and lower levels of 
MnSOD found in African Americans with T2D than in Haitian Americans with 
T2D, indicating higher oxidative stress among African Americans. 
The mitochondria produce superoxide ions, the most abundant ROS 
produced, that may participate in the damage of cellular macromolecules.  There 
is evidence that superoxide has an association with the development of diabetes 
complications and that MnSOD is the first line of defense in neutralizing 
superoxide in the mitochondria (Du et al., 2003; Brownlee, 2005).  This study 
showed that the serum levels of MnSOD were higher in African Americans than 
Haitian Americans.  Upon closer examination, the serum MnSOD levels of 
African Americans were lower for those with diabetes compared to without 
diabetes.  These finding supported previous reports of decreased MnSOD 
activity in white blood cells of participants with diabetes compared to those 
without diabetes (Wegner, et al., 2014; Kazi et al., 2008).   These findings may 
be interpreted that the mtDNA is not being protected efficiently due to the reduce 
MnSOD level and could lead to development diseases associated with T2D.  
Additionally, it was observed that dietary manganese intake level was lower in 
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African Americans compared with Haitian Americans, and since manganese is a 
cofactor for the production of MnSOD, then may indicate a need for an improved 
quality in their diet.   Currently there is no information available in the literature 
on serum levels of MnSOD in African American versus Haitian Americans. 
The significant differences in serum levels of MnSOD and 8OHdG 
among African Americans and Haitian Americans provide evidence of ethnic 
difference within the black population.  African Americans group had greater 
levels of both MnSOD and 8OHdG when compared with Haitian Americans.  
These observations also suggest that there appears to be ethnic differences in 
T2D, a major risk factor for CVD, therefore therapeutic interventions need to be 
managed according to ethnicity.  To the best of our knowledge, this is the first 
time that these differences were determined.  
The method that is used to quantify the serum levels of 8OHdG in this 
study was based on the ELISA principle, and has been validated and critically 
reviewed by Helliwell et al. (1996).  The ELISA method is believed to be 
advantageous over analytical methods such as HPLC and gas 
chromatography/mass spectrometry.  This is due to the elimination of artificial 
8OHdG which may be introduced during the isolation of DNA, especially in 
phenol-based DNA purification procedures (Claycamp, 1992).  The fact that we 
were able to identify significant association between 8OHdG and MnSOD 
suggest that cross-reactivity was not likely to interfere with the validity of the 
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assay.  In addition, the intra-assay coefficient of variation, 8.5%, indicates that 
the ELISA assay had repeatability.  
A two way ANOVA showed that ethnicity and diabetes status had a 
significant relationship with 8OHdG.  Higher levels of serum 8OHdG were 
found in T2D group compared to those participants without T2D.  In addition, 
lower serum 8OHdG levels were found in Haitian Americans with T2D 
compared with African Americans with T2D.  The role of MnSOD is to protect 
mtDNA from oxidative stress, and the data showed that MnSOD was higher 
while 8OHdG was lower in Haitian Americans than in African Americans.  The 
strength of this observation was considered to be large since the effect size was 
large for both main effects.  These findings indicate that there was more mtDNA 
damage in the T2D groups, of which African Americans may have a greater risk 
of T2D associated complications when compared with Haitian Americans with 
T2D.   
The positive correlation of 8OHdG and BMI in the diabetic group 
suggests that obesity may have an additive effect with increased fasting plasma 
glucose in oxidative mtDNA damage. The covariates were age, gender, smoking 
status, education, BMI, and energy intake.  Similar results were reported by Al-
Aubaidy et al. (2011) in their clinical study on oxidative DNA damage and 
obesity in T2D mellitus.  They also suggested that serum 8OHdG levels were 
already increasing in prediabetes. 
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One of the risk factors for diabetes is smoking, which may contribute to 
elevated levels of ROS.  Isik et al. 2007 showed that smoking may contribute to 
ROS through the weakening of the primary antioxidant defense system and 
production of free radicals.  The literature provides conflicting evidence of the 
relationship of 8OHdG in smokers and non-smokers.  In this study, we did not 
find any significant correlation of either 8OHdG or MnSOD with smoking, but 
this may be attributed to the low sample size of participants who were identified 
as smokers, thus the comparison may have lacked the power to detect a 
significant difference. 
There were significant differences found with 8OHdG and gender.  
Gender, in addition to smoking and BMI, was also reported in the literature as 
significant predictor of increased 8OHdG levels (Loft, et al., 1992).   
Although there was a weak relationship in the overall correlation between 
Ln-MnSOD and 8OHdG, there is evidence that higher serum 8OHdG levels were 
associated with lower serum MnSOD levels.  The regression analysis of 8OHdG 
on MnSOD was significant, with covariates of ethnicities, diabetes status, age, 
gender, education, energy intake, BMI, and smoking status.  However, after 
controlling for all covariates, MnSOD did not explain the significance and 
additional variability of 8OHdG.  In the final model, significant covariates were 
being male, African American, and having with T2D. 
We examined the relationship between dietary antioxidants intakes and 
found that serum 8OHdG levels negatively correlated with vitamin C intakes.  
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That is, lower dietary intake of vitamin C was found to be associated with higher 
levels of 8OHdG.  Similar results were reported by Moller et al. (2002) in a 
dietary antioxidant intervention study.  This observation may be due to the 
possible protection of the mtDNA from oxidative stress.  Also, we observed a 
negative correlation between dietary carotenoids intakes with MnSOD and 
8OHdG.  There were no relationship observed between vitamin E and vitamin D 
with either MnSOD or 8OHdG.   
In T2D, uncontrolled blood glucose levels may participate in disease 
pathophysiology which is associated with DNA damage.  In this study, the 
findings were similar to the studies reported by Salem et al. (2012) in that 
subjects with T2D had greater DNA damage, higher levels of inflammation and 
oxidative stress, and were positively associated with higher levels of blood 
glucose levels.  Since high blood glucose levels may interfere with cell 
replication and adversely influence the death rate of cells, there is a need to study 
ways in which to maintain DNA integrity and also to reduce the abnormal levels 
of ROS.   
This study used A1C and FPG as indices glycemic control.  The data 
showed that there were ethnic differences in A1C where African Americans had 
lower A1C than Haitian Americans. These findings were similar to Vimalananda 
et al. (2011) study that compared diabetes control among Haitians, African 
Americans, and Non-Hispanic Whites.  Although Haitian Americans appear to 
consume less carbohydrate than the African Americans, the Haitian Americans 
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had worse glycemic control.  These findings may suggest that MnSOD may 
contribute to glycemic control, but proper medication use may be a major factor 
and this study was not designed to address this variable. Although findings of a 
negative relationship with glycemic control and serum MnSOD levels were not 
found in the scientific literature for Haitian Americans, a similar relationship was 
observed in Type 1 diabetes patients by Wegner et al. (2014).  The report did not 
identify the ethnicity of the type 1 diabetes patients.  
There was a marginal association of fasting plasma glucose with vitamin 
E, and vitamin D.  Vitamin E intakes were not significant with FPG, but it 
explained some variance and it was marginally significant.  In addition, dietary 
intake of vitamin D was found to be associated with lower fasting plasma 
glucose.   Dietary intakes of vitamin D were not significantly associated with 
FPG, but it explained a small but significant variance in FPG.  Saedisomeolia et 
al. (2013) had different findings in their cross-sectional study.  They observed a 
positive relationship between serum vitamin D levels with glycemic control in 
Iranians, where 82% of the participants with T2D and 75% of the participants 
without T2D were either vitamin D deficient or insufficient.  The researchers 
interpreted these findings that vitamin D had beneficial effect on glycemic 
control. 
Strengths of the Study 
 This study is the first to report on the serum levels of MnSOD and 
8OHdG in Haitian Americans with and without T2D, and it also provided data 
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on the relationship between these oxidative stress biomarkers with dietary and 
glycemic control indicators.  This study provides evidence that there are ethnic 
difference in African American and Haitian American in dietary intakes, 
glycemic control indicators and oxidative stress levels components.  This implies 
that educators and clinicians should be cognizant that treatment modalities 
should be ethnically based. 
The instruments used in this study for data collection from the subjects 
were validated and standardized.  The research personnel were trained to 
properly and accurately use the instruments and also correctly complete and 
score the questionnaires used to gather information from the participants.   
 The participants of this study were provided a copy of the results of their 
cardiovascular risk analysis, blood glucose levels, A1C, and lipid profile as 
determined from the blood collected and, in some cases, they were alerted to 
cardiovascular risk that they were not aware or would have identified if it was 
not for this study.   
Limitations of the Study 
A limitation of this study was that it was cross-sectional design and 
provided a snapshot relationship.  In addition, although a validated nutrition 
assessment questionnaire was used to assess the dietary intake of antioxidants, it 
relies heavily on the subjects recall biases and estimate of portion size (Samuel-
Hodge et al., 2004; Olendzki et al., 2014).  The results of this study should be 
interpreted with caution and indeed, the lack of association between 8OHdG and 
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dietary antioxidants could have a more favorable outcome if antioxidant levels 
were determined from serum or plasma. The study design was observational and 
the results may not be interpreted to have causality effect.   
Conclusion and Recommendations 
This study found inverse relationship between serum MnSOD and 
8OHdG; suggesting that serum MnSOD and 8OHdG are useful biomarkers of 
oxidative stress in subjects with T2D.  We found that there were decreased serum 
levels of MnSOD in participants with T2D when compared to participants 
without T2D, and that there were elevated levels of 8OHdG present in 
participants with T2D indicating higher oxidative stress in persons with T2D. 
Additionally, we observed ethnic differences  between African 
Americans and Haitian Americans with T2D, showing lower oxidative stress 
among diabetic Haitian Americans associated with higher intake of dietary 
antioxidants.  The dietary antioxidants zinc and vitamin C were inversely 
correlated with 8OHdG suggesting that dietary intakes of antioxidant may 
provide health benefits by reducing mtDNA damage. 
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Cardiovascular Disease Risk 
Study 
in Haitian & African-American 
 
You are invited to participate in a study 
conducted at Florida International 
University  
by Dr. Fatma G. Huffman  
 
 
Criteria to enroll: 
 You must be Haitian or African-American  
 You must be 35 years old or older 
 You must agree to give three tablespoons of blood to 
test glucose levels and other biochemical tests 
 You must agree to give a urine sample  
 
You will receive information on your diet, physical 
activity level, body mass index, blood pressure and 
laboratory blood analysis. The whole process generally 
takes 3 hours. 
 
 
You will receive $ 75.00 upon completion of the study
 
 
For information, please contact:  
Dr. Fatma G. Huffman: 305-348-6427 or huffmanf@fiu.edu  
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Etid sou maladi Kadiovaskilè  Lakay 
Ayisyen ak Afriken-Amériken 
 
 
Nou invité ou pou ou kapab patisipé nan yon 
étid  Ké Dr. Fatma G. Huffman ap fè Nan 
Florida International Université 
 
Kondisyon pou kapab patisipé nan étid sa-a: 
 Ou sipozé Ayisyen ou byen Afriken-Amériken 
 Ou sipozé genyen 35 ans ou plis 
 Aksepté ké yo pran kèk gout san sou ou min-m pou yo 
kapab tchéké sik ou avèk lòt analiz nan san ou. 
 Aksepté pou ou bay yon ti échantiyon pipi 
Konsiltasyon a ap dire 3 zè de tan. Nan moman sa a,wap 
résévwa enfomasyon sou dayèt ou, enfomasyon sou aktivité
fisik ou, enfomasyon sou tensyon ou, plis lòt résilta 
laboratwa. 
Kòm rékompans wap résévwa $75 pou patisipasyon ou 
 
Pou plis enfomasyon sou étid la, ou kapab kontakté: 
Dr. Fatma G. Huffman: 305-348-6427 or huffmanf@fiu.edu 
Gustavo Zarini: 305-348-6427 or gzarini@hotmail.com 
Erskine Clerjeune: 786-355-4589 or eclerjeune@yahoo.com 
E. Nelson: 954-479-1150 or Enels002@fiu.edu 
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Office of 
Research 
Integrity
Research 
Compliance, 
MARC 270
 
 
 
 
  
MEMORANDUM  
 
To: Michael McLean   
CC: Dr. Fatma Huffman 
File 
From: 
Jada Dixon, MJ, MPH, IRB Coordinator  
Date:   September 12, 2012 
Proposal Title: "Oxidative Stress Biomarkers in African 
and Haitian Americans with and without 
Type 2 Diabetes: The Relationship between 
 Serum Levels of Manganese Superoxide 
 Dismutase and mtDNA 
 8-hydroxy-2’-deoxyguanosine, 
 and Antioxidants" 
 IRB Exemption # 073112-01 
 
 
The Health Sciences Institutional Review Board of 
Florida International University has reviewed your 
study for the use of human subjects via the Exempt 
Review process.  Your study was deemed Exempt by 
the Institutional Review Board on July 31, 2012.   
 
As a requirement of IRB approval you are required to: 
1) Submit a completion report (Form B-2) upon 
completion of your project in order for the file to 
be closed. 
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ID #: _____________________ 
 
Date _____________________ 
 
 
 
 
 
 
CVD RISK STUDY: HAITIAN & AFRICAN AMERICAN 
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Section I - Demographics 
 
Please answer each of the following questions by filling in the blanks with 
the correct answers or by choosing the single best answer. 
 
Note:  For this survey, a Health Care Provider refers to a doctor, nurse 
practitioner, or physician assistant. 
Q1.  Age: ____________ years old 
 
Q2.  Birth date:  __ __ /__ __ /__ __ 
         ( Month / Day  /  Year ) 
 
Q3.  Sex:  1 Male  2 Female 
 
Q4.     Height: _______________ centimeters 
 
Q5.     Weight: _______________ kilograms 
 
Q6.      Waist Circumference: _______________ centimeters 
 
Q7.  What year were you first told you had diabetes?  (Please enter the year)  _____ 
Q8.  What is your marital status? (check one box)   
  1  Never married 
  2  Married 
3  Separated/Divorced 
  4  Widowed 
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Q9.   Which country were you born in? (check one box) 
  1  Haiti 
  2  United States of America 
  3  Other________________ 
   
Q.10 How long have you been in the United States of America? (check one box) 
  1  Less than one year 
2  One to three years 
  3  Four to six years 
4  Seven to ten years 
  5  Eleven to fifteen years  
  6  More than fifteen years 
 
 
Q11.  How much schooling have you had? (Years of formal schooling completed) 
(check one box) 
  1  8 grades or less 
2  Some high school 
  3  High school graduate or GED 
4  Some college or technical school 
  5  College graduate (bachelor’s degree) 
  6  Graduate degree 
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Q12.  Which of the following best describes your current employment status? 
 (check one box) 
  1   Working full‐time, 35 hours or more a week 
  2   Working part‐time, less than 35 hours a week 
  3   Unemployed or laid off and looking for work 
  4   Unemployed and not looking for work 
  5   Homemaker 
  6   In school 
  7   Retired 
  8   Disabled, not able to work 
  9   Something else?  (Please specify):  _______________________ 
 
 Q13.  How would you describe the insurance plan(s) you have had in the past 12 
months?   
(check all that apply) 
1  An individual plan – the member pays for the plan premium 
2  A group plan through an employer, union, etc. – the employer pays all or 
part of the plan premium 
3  U.S. Governmental Health Plan (e.g., Military, CHAMPUS, VA) 
  4  Medicaid 
  5  Medicare 
  6  I have not had an insurance plan in the past 12 months 
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Q14. Which of the categories best describes your total annual combined household 
income from all sources? (check one box) 
1  Less than $5,000 
2  $5,000 to $9,999 
3  $10,000 to $19,999 
  4  $20,000 to $29,999 
  5  $30,000 to $39,999 
6  $40,000 to $49,999 
7  $50,000 to $59,999 
8  $60,000 to $69,999 
  9  $60,000 to $69,999 
  10  $70,000 and over 
11  Don’t know 
 
Q15. How many person(s) age 18 years and over live in the same house you 
live?_______ 
 
 
Q16. What language do you prefer to write something? (check one box) 
1  Only Creole 
2  More Creole than English 
3  Both equally 
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  4  More English than Creole  
5  Only English 
 
 
Q17. What language do you prefer to speak with someone? (check one box) 
1  Only Creole 
2  More Creole than English 
3  Both equally 
  4  More English than Creole  
5  Only English 
 
Q18. What language do you prefer to read with something? (check one box) 
1  Only Creole 
2  More Creole than English 
3  Both equally 
  4  More English than Creole  
5  Only English 
 
Q19. Your smoking habit. (check one box) 
 
1  Never smoked cigarettes, cigars or a pipe 
2  I quit smoking cigarettes/cigars/pipes at least one year ago 
3  I smoke cigarettes: ________ cigarettes per day 
  4  I smoke cigar: _________ cigars per day 
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  5  I smoke pipe: _________ pipes per day 
6  I chew tobacco: __________ times per day 
 
 
 
Q20. In general, would you say your health is: (check one box) 
 
1  2  3  4  5 
Excellent  Very Good  Good  Fair  Poor 
 
 
 
Section II – Medication History 
 
Q21. Are you currently (in last 6 months) prescribed any medicine for the treatment of 
diabetes by your    physician? (check one box) 
 
 
 
 
                   
                   If “yes” check all the medication(s) that apply: 
                        
 
1  2 
No  Yes 
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 ORAL DIABETES MEDICATION(S):        1 No        2 Yes     
 
◨ If “yes” How many oral diabetes medication(s) you take? 
_________ 
      
 INSULIN:                                  1 No        2 Yes 
 
Q22. Are you currently (in last 6 months) prescribed any other medicine prescribed by 
your physician? (check one box) 
 
 
 
 
                 If “yes” check all the medication(s) that apply: 
 
Cholesterol:   1 No          2 Yes                   Hypertension:    1 No         2 Yes 
 
Diuretics:       1 No        2 Yes                   Depression:        1 No         2 Yes 
 
Aspirin:          1 No        2 Yes                    Pain Relievers:  1 No         2 Yes 
 
Estrogen Replacement Therapy:     1 No      2 Yes        
 
Other(s):____________________________________________________________
_____ 
 
1  2 
No  Yes 
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Q23. Are you currently (in last 6 months) taking any other non‐prescription medication 
(over‐the‐counter)? 
 
 
 
 
 
              If “yes” check all the medication(s) that apply: 
   
Antacids and Acid Reducers:  1 No          2 Yes 
 
Antidiarrheals:                         1 No          2 Yes 
 
Antiemetic Medicines:            1 No          2 Yes   
 
Antihistamines:              1 No          2 Yes 
 
Cough Medicines:                1 No          2 Yes                                
 
Decongestants:                         1 No          2 Yes 
 
Laxatives:               1 No          2 Yes 
 
Pain Relievers:               1 No          2 Yes 
 
1  2 
No  Yes 
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If “yes” check all the medication(s) that apply: 
 
Aspirin (Bayer, St. Joseph)      1 No   2 Yes                     Ibuprofen (Advil, Motrin)    
1 No   2 Yes 
 
Ketoprofen (Orudis KT)          1 No   2 Yes                      Naproxen (Aleve)                
1 No   2 Yes 
 
Other(s):____________________________________________________________
_____ 
 
 
Section III – Family History  
 
  Q24. Family history of diabetes (check all that apply)  
 
1  Your mother has diabetes  
2  Your father has diabetes 
3  Your son has diabetes 
  4  Your daughter has diabetes 
  5  You have no family history of diabetes  
6  You don’t know your family history of diabetes 
 
 
  Q25. Family history of premature coronary heart disease (check all that apply) 
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1  Your mother had coronary heart disease before age 65 years old  
2  Your sister had coronary heart disease before age 65 years old 
3  Your father had coronary heart disease before age 55 years old 
  4  Your brother had coronary heart disease before age 55 years old 
  5  You have no family history of coronary heart disease 
6  You don’t know your family history of coronary heart disease 
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Section IV – Support 
 
Q1. I want a lot of help and support from my family or friends in:   
      (circle one answer for each line) 
 
 
 
Strongly 
 Disag
ree 
 
Somewhat
Disagree 
 
 
Neutral
 
Somewhat 
Agree 
 
Strongly
Agree 
Does 
Not 
Apply
following my meal 
plan. 
1 2 3 4 5 N/A 
taking my 
medicine. 
1 2 3 4 5 N/A 
taking care of my 
feet. 
1 2 3 4 5 N/A 
getting enough 
physical activity. 
1 2 3 4 5 N/A 
testing my sugar. 1 2 3 4 5 N/A 
handling my 
feelings about 
diabetes. 
1 2 3 4 5 N/A 
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Q2. My family or friends help and support me a lot to:   
       (circle one answer for each line) 
 
 
 
Strongly
Disagree
 
Somewhat
Disagree 
 
 
Neutral
 
Somewhat 
Agree 
 
Strongly
Agree 
Does 
Not 
Apply 
a) follow my meal 
plan. 
1 2 3 4 5 N/A 
b) take my medicine. 1 2 3 4 5 N/A 
c) take care of my 
feet. 
1 2 3 4 5 N/A 
d) get enough 
physical activity. 
1 2 3 4 5 N/A 
e) test my sugar. 1 2 3 4 5 N/A 
f) handle my feelings 
about diabetes. 
1 2 3 4 5 N/A 
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Q3. My family or friends: (circle one answer for each line) 
 
 
 
Strongly 
Disagree 
 
Somewhat
Disagree 
 
 
Neutral
 
Somewhat 
Ag
 
Strongly
Agree 
a) accept me and my 
diabetes. 
1 2 3 4 5 
b) feel uncomfortable about 
me because of my 
diabetes. 
1 2 3 4 5 
c) encourage or reassure me 
about my diabetes. 
1 2 3 4 5 
d) discourage or upset me 
about my diabetes. 
1 2 3 4 5 
e) listen to me when I want 
to talk about my diabetes. 
1 2 3 4 5 
f) nag me about diabetes. 1 2 3 4 5 
 
 
Q4. Who helps you the most in caring for your diabetes? (check only one box) 
 
  1 Spouse 
  2 Other family members 
  3 Friends 
  4 Paid helper 
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  5 Doctor 
  6 Nurse 
  7 Case manager 
  8 Other health care professional 
  9 No one 
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Section V ‐ Diet Adherence Scale 
 
 Q1.  Has any health care provider or nurse    1 No   2 Yes   3 Not sure 
    told you to follow a meal plan or diet? 
    Never    Sometimes    Always
Q2.  How often do you follow a meal plan 
or diet? 
1   2  3  4  5 
 Q3.  Have you been told to follow a schedule for    1 No   2 Yes 
    your meals and snacks?   
 
 Q4.  Have you been told to weigh or measure   1 No   2 Yes 
    your food? 
 
 Q5.  Have you been told to use exchange lists or    1 No       2 Yes 
    food group lists to plan your meals?   
    Never  Sometimes    Always
Q6.  How often do you follow the schedule 
for your meals and snacks? 
1  2 3  4  5 
Q7.  How often do you weigh or measure 
your food? 
1  2 3  4  5 
Q8.  How often do you (or the person who 
cooks your food) use the exchange 
lists or food group lists to plan your 
meals? 
1  2 3  4  5 
Section VI ‐ Exercise Barriers Scale 
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For the following questions, please circle the appropriate response. 
(circle one answer for each line) 
 
Q1.  How often do you have trouble getting 
enough exercise because: 
 
Rarely 
   
Sometimes 
   
Often 
  a)  it takes too much effort?  1  2  3  4  5 
  b)  you don't believe it is useful?  1  2  3  4  5 
  c)  you don't like to do it?  1  2  3  4  5 
  d)  you have a health problem?  1  2  3  4  5 
  e)  it makes your diabetes more 
difficult to control? 
1  2  3  4  5 
 
Section VII – Education / Advice Received 
 
Q1.  Has your health care provider or nurse ever told you to take special care of your 
feet?  
(check one box) 
 
1 No      2 Yes  3 Not Sure 
 
 
Q2.  Has your health care provider or nurse ever told you to follow an exercise 
program? 
(check one box) 
 
1 No     2 Yes  3 Not Sure 
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 Q3. Has your health care provider or nurse ever told you to follow a meal 
plan or diet? 
  (check one box) 
 
1 No      2 Yes  3 Not Sure 
 
Q4.  Have you ever received diabetes education? (for example: attended a series of 
classes or  
series of meetings with a diabetes educator) (check one box) 
   
1 No      2 Yes  3 Not Sure 
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Section VIII ‐ Long‐Term Care Benefits Scale 
 
For the following questions, please circle the appropriate response. 
(circle one answer for each line) 
 
Q1.  Taking the best possible care 
of diabetes will delay or 
prevent:  
Strongly
Disagree
 
Disagree
 
Neutral 
 
Agree 
Strongly 
Agree 
  a)  eye problems  1  2  3  4  5 
  b)  kidney problems  1  2  3  4  5 
  c)  foot problems  1  2  3  4  5 
  d)  hardening of the arteries  1  2  3  4  5 
  e)  heart disease  1  2  3  4  5 
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Section IX ‐ Understanding 
Q1. How do you rate your understanding 
of: (circle one answer for each 
line) 
Poor  Good  Excellent
 a) overall diabetes care 1 2 3 4 5 
 b) coping with stress 1 2 3 4 5 
 c) diet for blood sugar control 1 2 3 4 5 
 d) the role of exercise in diabetes  1 2 3 4 5 
 e) medications you are taking 1 2 3 4 5 
 f) how to use the results of blood 
sugar monitoring 
1 2 3 4 5 
 g) how diet, exercise, and 
medicines affect blood sugar 
levels 
1 2 3 4 5 
 h) prevention and treatment of high 
blood sugar 
1 2 3 4 5 
 i) prevention and treatment of low 
blood sugar 
1 2 3 4 5 
 j) prevention of long-term 
complications of diabetes 
1 2 3 4 5 
 k) foot care 1 2 3 4 5 
 l) benefits of improving blood 
sugar control 
1 2 3 4 5 
 m) pregnancy and diabetes 1 2 3 4 5 
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Section X ‐ Self‐Care Adherence: 
 
For the following questions, please circle the appropriate response. 
(circle one answer for each line) 
 
    Never   Sometimes   Always 
Q1.  I keep my blood sugar in good 
control. 
1  2  3  4  5 
Q2.  I keep my glycated hemoglobin 
(HbA1C) in good control. 
1  2  3  4  5 
Q3.  I keep my weight under control.  1  2  3  4  5 
Q4.  I do the things I need to do for my 
diabetes (diet, medicine, exercise). 
1  2  3  4  5 
 
 
 
  
 164 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX H 
 165 
 
ID # _____________________
 
CVD RISK STUDY:  
HAITIAN & AFRICAN AMERICAN 
 
 
Weight: ____________lb   Weight: ____________kg 
 
Height: ____________ in   Height: ____________cm  
 
 
               BMI: ____________ 
 
 
Waist circumference: ____________in            Waist circumference: ____________cm
 
 
Blood Pressure: 1 
 
 
Systolic: ______________mm Hg   
 
 
Diastolic: _____________ mm Hg   
 
 
Blood Pressure: 2 
 
 
Systolic: ______________mm Hg   
 
 
Diastolic: _____________ mm Hg  
 
 
Average Blood Pressures 
 
 
Average Systolic: ______________mm Hg 
 
 
Average Diastolic _____________ mm Hg  
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Aim Hypotheses Variables Test 
1.  To determine 
differences in 
Serum MnSOD 
and 8OHdG by 
diabetes status and 
ethnicity.  
1a: Serum levels of 
MnSOD will be lower 
in participants with 
T2D as compared with 
those without T2D, 
independent of 
ethnicity. 
 
1b: Serum levels of 
8OHdG will be higher 
in participants with 
T2D when compared to 
those without T2D, 
independent of 
ethnicity. 
 
1c: There will be an 
inverse relationship 
between serum levels 
of MnSOD and 
8OHdG in participants 
with T2D, independent 
of ethnicity. 
Dependent Variables 
1a: MnSOD 
1b: 8OHdG 
 
Independent Variables 
Diabetes status, 
ethnicity 
 
Covariates 
Age, gender, smoking, 
education, BMI, 
energy intakes 
1a: ANCOVA 
 
1b: ANCOVA 
 
1c: Pearson’s 
correlation and 
multiple linear 
regression 
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2.  To examine the 
relationships of 
serum MnSOD 
and 8OHdG with 
various dietary 
antioxidants by 
diabetes status and 
ethnicity. 
2a:  Serum 8OHdG 
levels will be 
negatively associated 
with dietary intake of 
antioxidants, 
independent of 
diabetes status and 
ethnicity. 
2b:  MnSOD levels 
will be negatively 
associated with dietary 
intake of antioxidants, 
independent of 
diabetes status and 
ethnicity 
Dependent Variables 
2a: 8OHdG 
2b: MnSOD 
 
Independent Variables 
Dietary intake of 
antioxidants  (Vit E, 
Vit C, Vit D, 
carotenoids) 
Diabetes status, 
ethnicity 
 
Covariates 
Age, gender, smoking, 
education, BMI, 
energy Intakes 
 
2a: Pearson’s 
correlation and 
multiple linear 
regression. 
2b: Pearson’s 
correlation and 
multiple linear 
regression. 
3.  To examine the 
relationships of 
glycemic control 
(A1C and FPG) 
with various 
dietary 
antioxidants in 
T2D by ethnicity. 
3a:  There will be no 
relationship between 
serum A1C and dietary 
antioxidants in 
participants with T2D 
independent of 
ethnicity. 
3b:  There will be no 
relationship between 
fasting plasma glucose 
level and any of the 
dietary antioxidant 
intakes in T2D 
independent of 
ethnicity. 
Dependent Variables 
3a: A1C 
3b: FPG 
Independent Variables 
Dietary intake of 
antioxidants (Vit E, 
Vit C, Vit D, 
carotenoids) 
ethnicity 
Covariates 
Age, gender, smoking, 
education, BMI, 
energy intakes 
3a: Pearson’s 
correlation and 
multiple linear 
regression 
3b: Pearson’s 
correlation and 
multiple linear 
regression 
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